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ABSTRACT OF DISSERTATION

INVESTIGATING THE ROLE OF CHD7 AND SOX11 IN RETINAL CELL DEVELOPMENT AND
THE OCULAR COMPLICATIONS OF CHARGE SYNDROME
Proper formation of the visual system requires the precise interaction of several
embryonic cell lineages, including the neuroectoderm (forms the retina and retinal
pigment epithelium), surface ectoderm (forms the lens), mesoderm and cranial neural
crest cells (form the ocular blood vessels and anterior ocular structures). When this
process is disrupted structural birth defects such as coloboma result, leading to pediatric
visual deficits. Ocular developmental defects are often present in larger syndromic
disorders. One example is CHARGE syndrome, a genetic disorder characterized by
coloboma, heart defects, choanal atresia, growth retardation, genital abnormalities, and
ear abnormalities. Pathogenic variants in CHD7 have been identified as the most
common genetic cause of CHARGE syndrome, however the mechanistic details of how
these pathogenic variants result in ocular defects are poorly understood. Further work is
needed to understand the developmental pathways that control oculogenesis and
retinal neurogenesis, and to uncover the mechanism leading to the clinical phenotypes
observed in CHARGE.
This work focuses on investigating and developing tools to better understand the
function of Chd7 and Sox11 in retinal development and photoreceptor maintenance,
and how loss of expression causes the ocular phenotypes observed in CHARGE
syndrome. The neural retina is formed from the inner layer of the optic cup, and the
single pool of retinal progenitor cells ultimately differentiates into six different neuronal
classes and the Müller glia. The different retinal cell types are generated in a conserved
temporal order and lead to construction of the structures allowing for
phototransduction. CHD7, a member of the CHD family of ATP-dependent chromatin
remodelers, has been shown to have a role in neurogenesis in several different areas of
the nervous system including the brain, spinal cord, auditory, and olfactory structures;
however, little is known about its role in retinal development. The second gene of
interest, Sox11, is a member of the SoxC family of transcription factors and has been
shown to be a downstream target of CHD7 in brain neurogenesis. Knockdown of Sox11
in zebrafish results in microphthalmia, coloboma, brain, trunk, and heart defects, all
phenotypes observed in CHARGE syndrome. However, the connection between Chd7
and Sox11 in retinal development is still relatively unexplored.
Chapter 1 of this dissertation is a review of eye development with a focus on
retinal development, the ocular defects of CHARGE syndrome, and what is known about
the functions of Chd7 and Sox11. Chapter 2 focuses on characterizing the expression of

Chd7 in the developing retina of two animal models. Using two different mutant
zebrafish lines for Chd7, this work demonstrates that there is a role for Chd7 in retinal
neurogenesis and uncovers a novel role for Chd7 in photoreceptor maintenance.
Chapter 3 describes the development of a transgenic zebrafish line in which Sox11a
carries an in-frame epitope tag, which will allow for further study of Sox11a expression
and provides a tool for identification of its transcriptional targets. Chapter 4 describes
the process to establish mutant lines for both co-orthologues of Sox11, sox11a and
sox11b, and the beginning characterization of retinal phenotypes in sox11 mutants.
Chapter 5 is a discussion of conclusions from these studies and how these findings lead
to future work connecting Chd7 and Sox11 with retinal development and CHARGE
syndrome.
KEYWORDS: zebrafish, CHARGE syndrome, Chd7, Sox11, retina, development
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CHAPTER 1.
1.1

OCULAR DEVELOPMENT AND CHARGE SYNDROME

Introduction
Vision, one of our major senses, is considered the largest contributor to

perception of the world around us [1]. The visual system requires signals to be received
by the eye, processed through the retina, and interpreted by the brain. When
development of the visual system or eye structures are disrupted, congenital eye
defects and pediatric visual impairment may result. Pediatric visual impairment can be
life altering, affecting motor, language, emotional, social, and cognitive development
[2–6]. Disruptions in eye development and congenital eye defects are often found as
part of larger syndromic disorders, including the focus of this dissertation, CHARGE
syndrome, a genetic disorder characterized by coloboma, heart defects, choanal atresia,
growth retardation, genital abnormalities, and ear abnormalities.
Development of the visual system, specifically the eye and its structures, is highly
conserved among vertebrates, including human, mouse, and zebrafish [7]. Significant
amount of work has been completed to better understand pathways involved in ocular
morphogenesis and retinal development, however many questions remain about the
role and mechanism of individual genes in these processes. This chapter will describe
our current understanding of the development of the eye and the retina and will focus
on congenital defects that result when these processes are disrupted. This chapter will
also address current gaps in our knowledge of the pathways and genes implicated in
CHARGE syndrome phenotypes.

1

1.2

Vertebrate Ocular Development
Development of the vertebrate eye and ocular structures is a result of the

organized interactions of neuroectoderm (forms the retina and retinal pigment
epithelium), surface ectoderm (forms the lens), and periocular mesenchyme made up of
mesoderm and cranial neural crest cells (form the ocular blood vessels and anterior
ocular structures).
Briefly, early in vertebrate development, a single eye field is specified at the
border of the anterior neural plate [8]. Cells within this eye field express known eye field
transcription factors (EFTFs) including Pax6, Rax, Otx2, Six3, and Lhx2, among others,
and contains all necessary progenitors to form the neural portions of the eye [9].
Disruptions in the development in the eye field result in defects such as microphthalmia
(small eye) or anophthalmia (single eye or no eyes) (Figure 1.1A) [10,11].
The eye field is subsequently separated into two fields through the action of
Nodal/TGF-Β and Sonic hedgehog (Shh) signaling as the midline of the embryo is
established [12,13]. Disruptions in these pathways and abnormal segregation of the eye
field result in holoprosencephaly and cyclopia [14–16]. The two separate eye fields
evaginate away from the midline, forming the optic vesicles (Figure 1.1B) [17,18]. During
this evagination process, the neural retina, retinal pigment epithelium (RPE), and optic
stalk begin to be specified. The distal portion of the optic vesicle forms the neural retina,
expressing the homeobox gene Vsx2; the dorsal proximal portion forms the RPE,
expressing the transcription factor Mitf; and the ventral proximal portion forms the
optic stalk, expressing Pax2 [18–22].
2

Evagination of the optic vesicle also allows for the interaction with the surface
ectoderm. This interaction leads to the thickening of the surface ectoderm which
eventually forms the lens placode and is the initial step in lens formation (Figure 1.1C)
[24,25]. At the same time, the optic vesicle invaginates, forming the bilayered optic cup
(Figure 1.1D). This invagination is a result of distinct cellular events in each of the layers.
The distal layer shapes the presumptive retina through cellular basal constriction and
retinal rim involution [26–29]. The RPE is shaped by flattening of cells in the medial layer
that surround the outside and rim of the retina (Figure 1.1E) [30–32].
Furthermore, the optic vesicle and optic cup are receiving extrinsic signals from
the periocular mesenchyme. It has been shown that periocular mesenchyme, consisting
of mesoderm and neural crest cells, begin to migrate with the optic structures at the
stage of evagination of the optic vesicle [33–35]. These periocular mesenchyme cells
supply the signals for the specification of the RPE, differentiation of the optic stalk, in
addition to migrating into the optic cup to become anterior ocular structures such as iris
stroma and corneal endothelium [36].
As optic cup invagination is occurring, at the ventral portion near and within the
optic stalk, an opening known as the optic fissure forms. Fissure formation is the result
of the ventral edges of the optic cup and optic stalk approaching each other during
invagination but remaining separated. Control of fissure formation is both intrinsic to
cells of the optic cup in addition to contributions by surrounding tissue by secretion
through Hedgehog and Retinoic acid signaling, among others [37,38]. This opening
allows space for the entrance of developing hyaloid vasculature and exit of retinal
3

ganglion cell axons that bundle together to form the optic nerve. The fissure eventually
closes to encapsulate these structures. The underlying molecular events that mediate
fissure closure are a strong area of current research, however the general sequence of
events is widely accepted. The closure process includes apposition of the edges of the
fissure, followed by basement membrane rearrangement then epithelial remodeling
and tissue fusion, and finally intercalation of tissue [39]. Additionally, periocular
mesenchyme cells are required for fissure closure. Specifically, a subset of neural crest
cells and endothelial cells seem to be necessary for basement membrane
rearrangement [40–43]. When optic fissure formation or closure is disrupted, the birth
defect known as coloboma results [44]. Coloboma can occur solely or as part of larger
syndromic disorders and involves different portions of the eye, resulting in visual
impairment of varying severity depending on its location and size; coloboma will be
discussed further in a later section.
Finally, the anterior structures of the eye, -- cornea, iris and ciliary body -- are
forming during and after optic cup completion. The cornea forms with interactions
between the surface ectoderm and migrating periocular mesenchyme while the iris and
ciliary body are formed at the edges of the optic cup from proliferating periocular
mesenchyme cells [45,46].

4

Figure 1.1 Vertebrate Ocular Development

Figure 1.1 Vertebrate Ocular Development. Schematic representation of ocular
development stages from eye field specification (A) to bi-layered optic cup (E). See text
for process details. EF, eye field; N, notochord; OV; optic vesicle; LP; lens placode/pit;
POM, periocular mesenchyme; RPE, retinal pigment epithelium; NR, neural retina; L, lens.

1.3

Vertebrate Retinal Development
As stated above, the inner layer of the of the optic cup forms the neural retina.

The vertebrate neural retinal progenitor pool proliferates and differentiates into six
neuronal cell types; retinal ganglion cells (RGCs), amacrine cells, horizontal cells, bipolar
cells, and rod and cone photoreceptors; as well as one intrinsic glial cell type, the Müller
glia. These cells are organized in a conserved fashion across all vertebrates in three
nuclear layers and two plexiform layers. The outer nuclear layer (ONL) contains the light
sensitive rod and cone photoreceptors which then synapse with bipolar cells and
horizontal cells in the outer plexiform layer (OPL). The inner nuclear layer (INL) contains
the cell bodies of the bipolar, horizontal, amacrine, and Müller glial cells. The bipolar
and amacrine cells synapse with retinal ganglion cells in the inner plexiform layer (IPL).
The ganglion cell layer (GCL) contains the cell bodies of the retinal ganglion cells, whose
axons then exit the retina and bundle together, forming the optic nerve, which
transmits the visual signal to the brain. Müller glia span the entire retina and provide
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structural and functional support to the other retinal cells. This principal glial cell of the
retina maintains architectural organization in addition to synthesizing and
phagocytosing necessary products for retinal function and homeostasis. (Figure 1.2A).
Decades of work in the retina have shown that all these retinal cell types
differentiate from a single population of multipotent retinal progenitor cell pool [47–
51]. Furthermore, the spatiotemporal pattern of development and differentiation of
the distinct retinal cells is mostly conserved in vertebrates [52,53]. Here, the focus will
be on zebrafish with specific comparisons between mouse and human.
The bilayered optic cup formation is completed around 20 hours post
fertilization (hpf) in zebrafish and the inner neuroepithelial layer is the starting place for
retinal cell differentiation [54]. Retinal neurogenesis begins in a small region of the
ventronasal retinal neuroepithelium adjacent to the optic nerve (often referred to as
the ventral patch). The ganglion cells are the first cell type to differentiate, exiting the
cell cycle in a fan-shaped pattern that spreads from the ventral to dorsal retina between
24-36 hpf [55,56]. The cells of the inner nuclear layer follow the same fan-shaped
pattern of differentiation between 36 hpf and 4 days post fertilization (dpf) for
amacrine, horizontal, and bipolar cells [55,57,58] . Overlapping with this period,
photoreceptors also begin to develop with cone photoreceptors first appearing at 48
hpf and then rod photoceptors at 60 hpf. Cone photoreceptors start to differentiate
from the ventral patch and differentiation expands from this region to the dorsonasal
and dorsotemporal retina, similar to the the other retinal cell types [59]. For rod
photoreceptors, there is a small window where early differentiation is detectable in the
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ventral patch, then sporadic cells throughout the dorsal and central retina follow in an
uneven distribution and irregular pattern with clustering in the ventrotemporal retina
[60]. In the post-embryonic retina, rods are primarily derived from a multipotent stem
cell/Müller glia progenitor pool of the inner nuclear layer. These progenitors proliferate
and migrate through the INL to ONL where they transition based on specific gene
expression from progenitors to rod precursors, then to rod photoreceptors [61–63].
The last cells to differentiate, starting at 60 hpf, are the Müller glia [64,65].
The temporal progression of retinal neurogenesis is mostly conserved between
mouse and zebrafish with specific timepoints of early born cells (ganglion cells,
amacrine, horizontal and cone photoreceptors) developing between embryonic day 10
(E10) and postnatal day 1 (P1). The late born cells (rod photoreceptors, bipolar cells, and
Müller glia) develop in the first 14 postnatal days (P0-P14) [66,67]. In humans, this
process occurs between fetal week 10-18 for the early phase cells and fetal week 18-23
for the late born cells with some continued differentiation of photoreceptors occurring
after birth (Figure 1.2B) [68,69].
While the retina is fully differentiated in the mouse by fourteen days after birth
and in humans several months after birth, the zebrafish retina displays continual
growth, which occurs from a persistently neurogenic area at the retinal periphery. This
area, the ciliary marginal zone (CMZ), contains a pool of stem cells that allow for the
continual addition of retinal cells as the zebrafish grows, enabling the retina to maintain
appropriate cell density as the eye cup expands along with the body of the zebrafish
[70,71]. Furthermore, the zebrafish has the unique ability to respond to retinal damage
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with regeneration of retinal cells. In this case, Müller glia respond to damage by dedifferentiating and asymmetrically dividing to produce multipotent stem cells that can
regenerate all the lost retinal cell types [72–74].

Figure 1.2 Schematic of Vertebrate Retina and Order of Retinal Cell Differentiation

Figure 1.2 Schematic of Vertebrate Retina and Order of Retinal Cell Differentiation. A.
Diagram of vertebrate retina. The retina is composed of three nuclear layers: Outer
Nuclear Layer (ONL), the Inner Nuclear Layer (INL), and the Ganglion Cell Layer (GCL),
and two plexiform layers: Outer plexiform later (OPL) and Inner Plexiform Layer (IPL).
The synapses for the photoreceptors, horizontal, bipolar are in the OPL and amacrine,
bipolar, and ganglion are in the IPL. B. The order of retinal cell differentiation is
conserved across zebrafish, mouse and human. Most of this cell differentiation occurs
between 24 hours post fertilization (hpf) to 5 days post fertilization (dpf) in zebrafish,
embryonic day 10 (E10) to post-natal day 15 (P15) in mouse, and fetal week 10 (Fw10)
to fetal week 23 (Fw23) in humans.
8

1.4

Photoreceptor Development
Vision requires that light be captured from the world around us. This process

entails anterior structures of the eye (cornea, pupil, iris, and lens) to allow for light to
enter, pass through, and focus correctly on the retina. Light hitting the retina must then
be captured by the light sensitive cells, the photoreceptors. Photoreceptors have a
distinct morphology to allow for this light sensitivity [75,76]. Rod and cone
photoreceptor cells have five main regions: the outer segment, connecting cilium, inner
segment, nuclear body, and synaptic region. Outer segments contain membranous disks
(rods) or folds (cones) which enclose opsins, the light-sensitive G-protein coupled
receptor proteins responsible for the detection of light. The photopigment molecule of
rods, rhodopsin, allows for the detection of dim light while the opsins of cones (red,
green, and blue) allow for color vison and higher visual acuity. The outer segments of
rods have a long cylindrical shape whereas cones have a shorter conical shape.
Capturing of light in these photopigment molecules of the outer segment initiates the
phototransduction pathway allowing for light to be converted to an electrical signal that
is transmitted to the second-order neurons of the retina. The connecting cilium
connects the outer and inner segments and provides a channel to allow for important
proteins to pass from the cell body and nuclear region to and from the outer segment.
The synaptic region is the site of transfer of neurotransmitters to retinal bipolar cells
and the horizontal neurons.
The development of the outer segments of photoreceptors and their contained
structures and proteins are essential for visual function. The outer segment resembles
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the structure of a primary sensory cilia and develops in a similar manner. First, during
initial photoreceptor development, the axoneme/cilium projects from its basal body
located in the inner segment. This primitive cilium contains vesicles and tubules of
“morphogenetic material” that will establish other structures of the outer segments.
Second, the apical region of the cilium enlarges as the material is used to form
beginnings of disks. Third, these primitive disks are then remodeled and reoriented to
their final transverse position. As a result of these three steps the outer segment is
formed by morphogenetic and differentiation events of the distal region of the primitive
cilia. The undifferentiated basal portion remains continuous with the basal body and
becomes the connecting cilium [77,78]. Outer segment morphogenesis has been
detected starting at 60 hpf in zebrafish and P8 in mice and continues until adult
dimensions are met [77,79] . Outer segments are further maintained throughout life by
undergoing constant renewal. New disks are continually being synthesized at the base
of outer segments which leads to elongation of the outer segment. At the distal outer
segment of the photoreceptor, the oldest disks are then shed and are phagocytosed by
the RPE [80].
Although photoreceptor function is conserved across species, the spatial
organization and distribution of rods and cones varies based on evolutionary strategies.
In humans, this means a peripheral retina that is rod dominant with a central region, the
macula, which has a higher density of cones and a fovea with only cones allowing for
our high visual acuity [81]. In contrast, nocturnal mice are rod dominant throughout
their retina and only contain two types of cones, short and medium wavelength [82].
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The zebrafish has a cone-rich retina, possessing 60% cones, similar to the macula of
humans and reflecting their diurnal lifestyle [83–85]. In addition, zebrafish contain a
fourth cone subtype that responds to ultraviolet light. The four cones in zebrafish are
arranged in a unique geometric mosaic pattern in which red/green double cones are
always located next to blue cones on the red cone side and UV cones on the green cone
side. Furthermore, in adult zebrafish, four rods form a square surrounding the UV cones
[83].
Much work has been done to investigate the many different signals and
pathways involved in the process of photoreceptor development. This work has shown
that progenitor cells are not limited to a specific path but instead during proliferation or
post mitotically, precursors encounter different specification events leading to their
fate. Furthermore, the pathway and sequence of events are generally conserved among
vertebrates [86,87]. These events that control specification are from intrinsic gene
expression programs as well as extrinsic signals and can be both positive (acquiring an
event/signal) or negative (restricting another event/signal).
Briefly, the photoreceptor progenitor pool is fist specified by the expression of
the transcription factors Otx2 and Crx. When Otx2 is absent, photoreceptors do not
develop and instead there is an increase in amacrine like cells [88–90] while defective
photoreceptor development and degeneration occurs when Crx is absent [91].
Additionally, NeuroD, a bHLH transcription factor, is present in the rod progenitor pool
of the inner nuclear layer as well as cone progenitor pool and has been implicated in
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controlling cell cycle regulation and cellular proliferation of precursors [92,93]. This
photoreceptor precursor pool is then further specified into rod and cone subtypes.
Expression of the transcription factor Nrl is required for the rod photoreceptor
fate [94]. Nrl, a basic leucine zipper transcription factor, promotes the expression of
important downstream rod photoreceptor genes including the orphan nuclear receptor
Nr2e3, which is responsible for activating other rod specific genes as well as repressing
cone specific genes like S-opsin [95–97]. Defects in both Nrl and Nr2e3 lead to nonfunctional rods in mice and the genetic disorder of S-cone syndrome is attributed to loss
of Nr2e3 in humans and results in a fate switch from rods to S-cones [94,98].
For cones, it’s a little more complicated and not as clear when discussing subtype
specification. In zebrafish, two progenitor cone populations form. One population
expresses the homeobox transcription factor Six7 and can only form green cones. A
second population expresses the bone morphogenetic protein (BMP) ligand Gdf6a and
differentiates into three distinct subtypes of cones based on additional expression of
downstream genes [99]. If Gdf6a is solely expressed, the cells become blue cones; if
Gdf6a and thyroid hormone receptor beta (Thrb) are expressed the population becomes
red cones. Finally, if Gdf6a and T-box transcription factor 2b (Tbx2b) are co-expressed
the population differentiates into UV cones [100]. In mice, which only have short (blue)
and medium (green) wavelength cones, disruption of Thrb results in mice deficient for
M-opsin and an overabundance of S-opsin [101,102].
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Several extrinsic signaling pathways have also been shown to have a role in
photoreceptor development and specific opsin expression. These factors include (but
are not limited to) Fgfs, Wnts, Shh, retinoic acid (RA), Notch and thyroid hormone (T3)
and changes in their morphogen concentration gradients lead to loss of photoreceptors
and differential opsin expression patterns [103,104]. Briefly, in zebrafish, Hedgehog
signaling from the RPE is associated with the wave-like differentiation of photoreceptors
and when disrupted, differentiation is halted resulting in a decrease in photoreceptors
[105]. In chick and rat in-vitro experiments, retinoic acid was shown to be essential for
differentiation and survival of photoreceptors and recently has been shown to
accelerate photoreceptor development in retinal organoids [106–108] . Furthermore,
retinoic acid-treated zebrafish showed altered photoreceptor differentiation, resulting
in an increased number of rod photoreceptors and red-cones, and a decrease in number
of blue and UV cone photoreceptors [109,110]. Finally, Notch signaling has been shown
to maintain proliferative potential of retinal progenitors and the transition to
photoreceptors precursors. An early loss of Notch signaling has been shown to lead to
an increase in the number of cones and later loss of signaling leads to an increased
number of rods [111].
While much has been learned about the intrinsic transcription factors and the
external signaling that influences photoreceptor development, there still remain gaps in
our knowledge about the contribution and timing of these genes and factors, as well as
additional photoreceptor genes that participate in this process.
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1.5

Congenital Ocular Defects and Syndromic Disorders
Development of ocular structures and retinal cells require precise spatial and

temporal organization. When these spatial or temporal dynamics are disrupted by
pathogenic variants, congenital ocular and retinal defects can lead to visual
impairment. These defects include three main groups: optic cup, anterior segment, and
retinal disorders (Table 1.1) [112]. Optic cup abnormalities are present when formation
of the eye field, and/or proper bilateralization and evagination are disrupted leading to
anophthalmia (absence of the eye), or microphthalmia (smaller than normal eye)
[113,114]. Coloboma is also a part of this group and is a consequence of the optic fissure
not closing properly, which affects the iris, choroid, retina, and optic nerve [115].
Anterior segment deficits involve the structures of the cornea, iris, ciliary body, and lens
leading to aniridia, anterior segment dysgenesis, Axenfeld-Rieger anomaly, and Peters
Anomaly [116–118]. Retinal disorders are those that effect the neurons of the retina
and most commonly the photoreceptors. These defects include cone-rod dystrophy,
Leber congenital amaurosis, and retinitis pigmentosa and result when the genes
responsible for function and maintenance of the photoreceptors are disrupted leading
to photoreceptor degeneration [119–122].
While some of these defects are rare, a child’s vision and their future
development can be strongly impacted. In fact, coloboma accounts for up to 10% of
pediatric blindness [123]. In addition, these congenital defects may present as the sole
developmental defect or as part of a larger syndromic disorder. Axenfeld-Rieger
anomaly and Peters Anomaly can be part of larger syndromes (Axenfeld-Rieger
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syndrome and Peters plus syndrome), in which affected individuals have both eye
anterior segment defects in addition to craniofacial defects, dental anomalies, short
stature, and intellectual disability[124,125]. Retinal cell defects are present in
syndromic disorders such as Usher syndrome, Bardet-Biedl, Joubert, and Senior-Løken
syndrome. In Usher syndrome, the affected individual has retinitis pigmentosa and faces
a range of hearing loss and balance concerns [126]. In Bardet-Biedl syndrome, most
affected individuals have cone-rod dystrophy and are legally blind by adolescence, in
addition to other characteristics such as obesity, polydactyly (extra fingers and toes),
intellectual disability, and genital abnormalities [127]. Individuals with Joubert
syndrome can display brain abnormalities along with muscle, skeletal, kidney, liver and
retinal dystrophy [128]. Senior-Løken syndrome is characterized by the combination of
Leber congenital amaurosis and loss of photoreceptors with the kidney condition
of nephronophthisis [129]. Finally, microphthalmia, anophthalmia, and coloboma,
collectively referred to as MAC, can occur in isolation or alongside those of brain and
craniofacial defects, signifying the similar signaling pathways responsible for the
formation of head structures. One example is CHARGE syndrome, a genetic
neurocristopathy characterized by coloboma, heart defects, choanal atresia, growth
retardation, genital abnormalities, and ear abnormalities [130].
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Table 1.1 Congenital Ocular Defects
Major Characteristics
Loss of Iris
Aniridia
Anterior
Underdeveloped iris,
Segment
cornea defects, ciliary body
Dysgenesis
defects, lens defects
Axenfeld-Rieger
Defects in iris and pupil
Anomaly

Additional Ocular
Major Genes
Frequency
Characteristics
Anterior Segment Defects
Misshapen pupil,
1 in 50,000 to
PAX6, FOXC1, CYP1B1
glaucoma, cataracts
100,000
Glaucoma, cataracts

More than 15 genes;
PITX2, FOXC1, PITX3

Varies

Glaucoma, cataracts

PITX2 and FOXC1

1 in 200,000

FOXC1, PAX6, PITX2,
CYP1B1

3 to 6 in
100,000

More than 75 genes;
SOX2, RAX, OTX2, PAX6

1 in 20,000

More than 50 genes;
SHH, PAX6, GDF3, VAX2

1 in 10,000

More than 50 genes;
RAX, SIX6, OTX2, SHH,
SOX2

1 in 10,000

More than 30 genes;
ABCA4

1 in 30,000 to
40,000

Amblyopia, glaucoma,
cataracts
Optic Cup Defects

Peters Anomaly

Opaque cornea

Anophthalmia

Loss of one or both eyes

n/a

Coloboma

Lack of optic fissure closure

Cataracts, glaucoma,
myopia, nystagmus,
retinal detachments

Microphthalmia

Small eye

Cataracts, microcornea

Cone - Rod
Dystrophy
Leber
Congenital
Amaurosis
Retinitis
Pigmentosa

Loss of cones then rod
photoreceptors
Loss of photoreceptors

Usher
Syndrome

Loss of rods then cone
photoreceptors

Bardet-Biedl
Syndrome
Joubert
Syndrome
Senior-Løken
Syndrome

1.6

Loss of rods then cone
photoreceptors

Loss of cones then rod
photoreceptors
Loss of rods then cone
photoreceptors
Loss of photoreceptors

Retinal Cell Defects
Nystagmus

Nystagmus, keratoconus, More than 15 genes;
poor pupillary reflex
CEP290, CRB1, RPE65

2 to 3 in
100,000

1in 3,000 to
4,000
4 to 17 in
MYO7A, CDH23,CLRN,
100,000
n/a
USH2A
people
1 in 140,000
More than 15 genes;
to 1 in
n/a
BBS1, BBS10,
160,000
More than 30 genes; 1 in 80,000 to
Coloboma
CEP290, KIF7, NPHP1 1 in 100,000
Nystagmus, keratoconus,
CEP290,
1 in 1,000,000
poor pupillary reflex
NPHP1,WDR19,NPHP4
n/a

More than 60 genes;
RHO, USH2A

Clinical Presentation of CHARGE Syndrome
The syndrome now known as CHARGE was first described in 1979 through two

different cohorts of individuals with ear, ocular, cardiac, craniofacial anomalies, and
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intellectual disability [131–134]. Two years later another cohort of individuals was
described, and the publishing group proposed the acronym CHARGE: C-coloboma, Hheart disorders A-atresia choanae, R-retarded growth and retarded development and/or
CNS anomalies, G-genital hypoplasia, and E-ear anomalies and/or deafness [135] (Figure
1.3). The prevalence of CHARGE syndrome is estimated to be between 1 in 10,000 to 1
in 15,000 live births.
Since first described, phenotypic reports have expanded, resulting in more detail
and a wider range of possible phenotypic presentations. Ocular defects include
coloboma and microphthalmia and will be discussed in more detail in section 1.8 [136].
Heart defects include a wide spectrum of congenital abnormalities including aortic arch
interruption, tetralogy of Fallot, double outlet right ventricle, arch vessel anomalies, and
atrioventricular septal defects [137]. Craniofacial and upper respiratory malformations
include choanal atresia (narrowing of nasal cavity), orofacial clefts, tracheoesophageal
fistulas along with characteristic facial features of prominent foreheads and nasal
bridges [138]. Growth and developmental anomalies involve central nervous defects,
cranial nerve abnormalities, short stature, and intellectual delays [139–142]. Genital
abnormalities include genital hypoplasia and late puberty [143]. Ear abnormalities
involve cup shaped outer ear, triangular concha, ossicular malformations, absence or
hypoplasia of semicircular canals and sensory hearing deficits [144–147].
The expansion of the phenotypes described can be partially attributed to
identification of the major causative gene, CHD7, which is reported to be mutant in 70
to 90% of CHARGE syndrome cases [148–150]. In addition, this wide spectrum of
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phenotypes has resulted in several different published clinical diagnostic criteria
centered on major and minor characteristics [151–153]. The latest proposed criteria
suggest a CHARGE diagnosis based on 2 major and any number of minor characteristics
[154] (Table 2.2). One of the major characteristics is a pathogenic variant in CHD7,
which has been the focus of CHARGE Syndrome research to further understand the
diverse spectrum and mechanism of phenotypes observed and will be discussed more in
section 1.7.
Figure 1.3 CHARGE Syndrome

Figure 1.3 CHARGE Syndrome. Original phenotypic description leading to the acronym
for CHARGE Syndrome. See text for more details.
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Table 1.2 CHARGE Syndrome Diagnostic Criteria [154]
CHARGE Syndrome Diagnostic Criteria
Major (2 or More)

Minor

Coloboma

Cranial nerve dysfunction

Choanal atresia or cleft palate

Dysphagia/feeding difficulties

Abnormal external, middle, or
inner ears

Structural brain anomalies

Pathogenic CHD7 variant

Developmental delay
Hypothalamo-hypophyseal
dysfunction (gonadotropin or
growth hormone deficiency) and
genital anomalies
Heart or esophagus malformation
Renal anomalies
Skeletal and limb anomalies

1.7

CHD7 and CHARGE Syndrome
CHD7 is a member of the chromodomain helicase-DNA binding domain (CHD)

family of proteins. CHD members have specific non-redundant roles in the processes
involved in chromatin manipulation using ATP-hydrolysis [155–157]. Members of this
family have two conserved motifs: two chromodomains located in the N-terminal
region, and the SNF2-like ATPase domains located in the central region, with other
domains less well characterized at the C-terminus [158]. In general, CHD7 has been
shown to be responsible for nucleosome mobility, recognizing unique target sites to
allow for the removal and sliding of the histone octamer thus leading to DNA access
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[159]. This chromatin manipulation is essential for DNA transcription, replication, and
repair, making CHD7 a vital gene for normal development [160]. Specifically, CHD7 has
been shown to work in a tissue-specific manner to control target gene expression by
acting solely or as member of a complex with other transcription factors [161,162]. This
tissue-specific gene expression control has been found to be essential for cellular
proliferation and differentiation in addition to maintenance of adult neural stem cell
populations [163,164].
Heterozygous pathogenic variants in CHD7 are identified in 70 to 90% of clinically
diagnosed individuals with CHARGE [148–150]. With over 500 pathogenic variants
spanning the entirety of the 38-exon gene (2997 amino acids, ~336 kD protein), 90% of
the variants are nonsense, frameshift, and splice site variants resulting in a truncated
protein [165]. In addition, pathogenic variants in CHD7 have been reported in clinical
cases of Kallmann syndrome, which is a disorder involving hypogonadotropic
hypogonadism (deficit in gonadotropin-releasing hormone) and hyposmia or anosmia
(diminished or lack of smell) [166]. Interestingly, 70% of variants found in CHD7 causing
Kallmann syndrome are missense variants [167]. Since identification of CHD7 as a
causative gene in CHARGE syndrome, research has focused on understanding its role in
the affected tissues. The following sections will focus on the ocular complications of
CHARGE syndrome and the role that CHD7 plays in the development of the eye.
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1.8

Ocular Complications of CHARGE Syndrome
Clinical reports indicate that coloboma is present in over 80% of clinically

diagnosed individuals with CHARGE. The colobomas range in severity and involvement
of the retina, choroid, lens, and iris. While the majority of the observed colobomas are
bilateral, some individuals present with unilateral ocular defects. In addition to
coloboma, other ocular complications including microphthalmia, optic nerve hypoplasia,
nystagmus, cataracts, amblyopia, microcornea, strabismus and rarely angle closure
defects and retinal detachment have been reported [168–176].
While ocular structural defects have been identified in different case reports and
phenotype reviews of CHARGE syndrome, we lack an understanding of the correlation
between the extent of ocular defects and an individual’s visual acuity. This is partially
due to the complex clinical presentation of CHARGE syndrome, which often imposes
limits on performing normal vision assessment methods. Recently several groups have
tried to address this lack of connection. First, the VISIOCHARGE questionnaire combined
ophthalmological findings with a self-and/or guardian administered questionnaire
assessing distance-vision, near-vision, and overall vision. This group concluded that
visual skills of everyday life were relatively good even in the presence of severe ocular
structural defects, such as bilateral colobomas, and there was no association between
visual ability and the severity of ocular malformation [155]. However, this study has its
limitations based on the small size of the cohort and the nature of self-administered
questionnaires. More recently, the VISIOCHARGE questionnaire was combined with
adapted visual behavior assessments and ophthalmic assessments to better fit the
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complexity of clinical findings in CHARGE syndrome [178]. Visual behavior assessments
were adapted to measure the ability to fix, track, perform saccades, and assess visual
acuity and visual fields along with measuring contrast sensitivity, stereopsis, and
strabismus. Overall, this systematic assessment resulted in categorizing 57% of the
individuals with severe visual impairment. However, there was no correlation between
the extent of visual impairment and the severity of the ocular structural abnormality.
This study did identify a correlation between ocular abnormalities and the type of
pathogenic variants in CHD7, suggesting that earlier truncating pathogenic variants
resulted in more severe findings such as extensive colobomas. This study also has
limitations due to size, but leads to questions about why there is a lack of correlation
between ocular structural defects and assessed visual acuity. One possible explanation
is that loss of CHD7 results in additional retinal abnormalities that are currently
underdiagnosed in CHARGE syndrome. To further understand the full extent of ocular
complications of CHARGE syndrome, it is essential to better understand CHD7’s role in
eye development beyond the initial stage of ocular morphogenesis.
1.9

Role of CHD7 in Development of Ocular Structures
Xenopus, Drosophila, zebrafish, and mouse models have been established to

further study the development and mechanism of CHD7 and CHARGE syndrome [179–
181]. Homozygous loss-of-function mouse models are embryonic lethal at E10.5 while
heterozygous mice display characteristics like those of individuals with CHARGE
[182,183]. These models have been used to extensively study brain, ear, heart, and
craniofacial developmental phenotypes upon loss of CHD7 [180,183–186]. However, less
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work has concentrated on eye development in these models, partially due to the
complex contributions of multiple tissues in the eye.
One study that focused on CHD7 in mouse eye development used conditional
knockouts to delete Chd7 from various embryonic tissues that contribute to the eye
[187]. This work was the first detailed expression study in the eye and CHD7 was shown
to be widely expressed in early neural and surface ectoderm from E9.5-E12.5, the timing
of which corresponds to optic vesicle evagination at E9.5 through formation of the optic
cup and lens at E12.5 (Figure 1.4A). Furthermore, conditional knockouts of Chd7 in
surface ectoderm and/or neural ectoderm demonstrated that expression of CHD7 was
required in the neural ectoderm for proper ocular morphogenesis of the optic cup and
optic fissure closure. In addition, this work established and qualitatively described the
presence of coloboma in the Chd7 mutant mouse model which previously had not been
addressed.
Ocular structural defects upon loss of Chd7 in other species have been broadly
described but not rigorously investigated. Results of knockdown and knockout studies
contain general descriptions of microphthalmia, coloboma, and anterior defects, but an
in-depth understanding of mechanism or contribution of CHD7 to these defects is
lacking [188–193].
An area of focus for CHD7 research has been its role in neural crest cells, which
contribute to many of the structures affected in CHARGE syndrome [194]. Neural crest
cells are multipotent migratory cells that arise early in development and contribute to
tissues and structures in the heart, craniofacial skeleton, ear, eye, and peripheral
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nervous system, among others [195]. It has been shown that Chd7 is expressed in premigratory neural crest cells and when Chd7 expression is altered there is a decrease and
disruption of these cells [196,197]. Expression continues during neural crest cell
migration where CHD7 has been shown to target downstream genes such as Sox9,
Twist, and Snail 1/2 [179,198,199]. Furthermore, CHD7 has been shown to work in
conjunction with other transcription factors and chromatin remodeling complexes to
direct neural crest cell differentiation and when CHD7 is absent neural crest cell fates
are altered (Figure 1.8B) [200].
Concentrating on the eye, it is known that cranial neural crest cells contribute to
the periocular mesenchyme, which forms anterior ocular structures including the
cornea, ciliary body, iris, sclera, and aqueous humor outflow tract. Disruptions in neural
crest cells result in defects of these structures and congenital disorders such as
Axenfeld-Reiger syndrome and Peters Anomaly [36,46]. Neural crest cells also
secondarily play a role in optic cup formation and optic fissure closure, interacting with
the neural derived optic cup. disruptions in this process result in microphthalmia and
coloboma [201,202].
However, the exact role of CHD7 in the cranial neural crest cells that contribute
to ocular development is still unknown, creating a need for more investigation and
additional models. Anterior segment defects have been identified in individuals with
CHARGE suggesting that CHD7 may contribute to neural crest cells in the periocular
mesenchyme [136,203,204]. Models with live imaging and transgenic lines of zebrafish
that have fluorescently labeled neural crest cells are critical in delineating the exact role
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of CHD7. Furthermore, based on CHD7’s role in neural ectoderm and ocular structures,
conditional knockout models will need to be established to determine the contribution
from each cell type.

Figure 1.4 CHD7 Expression in Ocular Morphogenesis and Neural Crest Cell Development

Figure 1.4 CHD7 Expression in Ocular Morphogenesis and Neural Crest Cell
Development. A. Schematic representation of ocular development stages in mouse
from optic vesicle evagination at E9.9 to bi-layered optic cup at E12.5, CHD7 expression
is colored in red. OV; optic vesicle; LP; lens placode/pit; POM, periocular mesenchyme;
RPE, retinal pigment epithelium; NR, neural retina; L, lens. B. Schematic representation
of CHD7 expression in neural crest cell development, CHD7 expression is colored in pink.
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1.10 CHD7 in Neurogenesis
In addition to role of CHD7 in neural crest cell dynamics, CHD7 has strongly been
associated with tissue-specific neurogenesis. These associations are evident in many of
the systems affected in CHARGE syndrome which contain nervous tissue (Table 1.9). In
the ear, CHD7 has been shown to act upstream of pro-neural genes in inner ear
neuroblasts; mice lacking functional CHD7 have a smaller vestibulo-cochlear ganglion
and decrease in neuron number [205]. In the olfactory system, CHD7 is expressed in the
pro-neural basal cells during development and adulthood. When disrupted, there is
disorganization and a decrease in olfactory sensory neurons [206]. Gonadotropinreleasing hormone (GnRH) neurons are also reduced in the hypothalamus of
haploinsufficient CHD7 mice [207]. In other parts of the brain, there are examples of
CHD7 controlling neurogenesis in both development and adulthood. The neurogenic
areas of adult mammalian brain, the subventricular zone (SVZ) of the lateral ventricle
and the subgranular zone (SGZ) of the dentate gyrus in the hippocampus, show
expression of CHD7 in active neural stem cells and when inactivated there is a decrease
in adult neurogenesis [208]. During development, CHD7 is expressed in cerebellar
granule cells and loss of CHD7 in subsets of these cells leads to a decrease of
neurogenesis and eventual cerebellar hypoplasia [184,209–211].
Globally, CHD7 has been found to be a co-factor of Sox2, which is essential for
neural stem cell maintenance and neurogenesis in mouse. It also contributes to neural
progenitor differentiation in mouse embryonic stem cells where the loss of CHD7 results
in disruption of the number and complexity of new neurons [212,213]. In addition to
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mouse models, recent chd7 mutant and morphant zebrafish models have shown a
decrease in branchiomotor neurons of the hindbrain and GABAergic neurons in the
brain [181,214].
While the effects of CHD7 pathogenic variants on neurogenesis have been
studied for many regions of the central and peripheral nervous system, there is little
data available on whether loss of CHD7 alters retinal neurogenesis. As described above,
much of the focus of published literature has been on ocular morphogenesis and those
studies did not examine later timepoints that are relevant for retinal neuron
differentiation [187].
With the advancement of single-cell transcriptomics, large data meta-analysis
platforms have become more accessible to analyze specific tissue transcriptomics. This
is the case with the eye and the analysis platform eyeIntegration v1.05 from the
National Eye Institute which collates human eye tissue RNA-seq data with other human
body tissues [215]. When using this platform, Chd7 is shown to be globally expressed in
fetal human retina and postnatal retinal at levels equal to that of the cerebellum (Figure
1.5). These data suggest that CHD7 may have some functional role in both the
developing and mature retina.
Interestingly, morpholino-mediated knockdown of zebrafish chd7 was associated
with a decrease in retinal ganglion cells and photoreceptors in addition to global retinal
disorganization and laminar defects [181]. However, there have been no follow up
studies to further characterize this phenotype or elucidate contributions of Chd7 to the
retina. Taken together with the lack of correlation between the presence of ocular
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malformations and extent of visual impairment in individuals with CHARGE, this may
point to retinal neuron deficits as an additional feature of CHARGE syndrome, and thus
should be an avenue for future studies. Furthermore, recent work has shown that Chd7
plays a role in protecting hair cells of the ear from oxidative stress and loss of Chd7
leads to misregulation of stress response pathways resulting in degeneration [216].
Given that photoreceptors are sensory neurons with a high metabolic demand, the role
of Chd7 in their oxidative stress response also warrants investigation.
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Table 1.3 CHD7 and Neurogenesis
System

Neurons Effected

Cerebellum

Reduction in
cerebellar granule
neurons

Reln, Fgf8

Global Brain

Reduction in
GABAergic neurons

paqr3b

Autism-like
behavior,
attentiondeficit/hyperactivit
y disorder, anxiety,
aggressivity and
seizures

[214]

Sox4, Sox11

Development
delays

[208]

Hippocampus Decrease in adult
neurogenesis from
subventricular
zone (SVZ) of the
lateral ventricle
and the
subgranular zone
(SGZ) of the
dentate gyrus
Hypothalamus

Olfactory

Potential
Association with
Downstream
CHARGE
References
Targets of CHD7
Phenotype
Cerebellar
[184, 209hypoplasia leading
210]
to developmental
delays

Reduced
Fgfr1,Bmp4, Otx2 Hypogonads,
gonadotropingenital hypoplasia,
releasing hormone
and delayed
(GnRH) neurons
puberty

[207]

Reduced olfactory Mash1, NeuroD
bulb size and
reduced olfactory
neurons

Hyposmia and
Anosmia

[206]

Hearing loss and
balance disorders

[205]

Auditory and Vestibulo-cochlear
Vestibular
ganglion size and
neuron number

Ngn1, Otx2,
Fgf10
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Figure 1.5 CHD7 expression data gathered from eyeIntegration v1.05 platform

Figure 1.5 CHD7 expression data gathered from eyeIntegration v1.05 platform [215].
Box plot of Pan-Human Chd7 expression in fetal and adult retinal tissue (red outline)
compared to other tissues from single-cell sequencing data.
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1.11 Sox11: a potential target of CHD7 in eye development
The wide spectrum of phenotypes observed in CHARGE syndrome is not only a
result of the broad expression of CHD7 in development but also the wide range of
potential downstream targets of CHD7 transcriptional regulation. Generally, CHD7 has
been shown to bind regions distal to transcription start sites in the genome marked by
H3K4 methylation – the histone modification indicating active transcription. This
epigenetic signature of histone methylation and correlation with CHD7 binding signifies
the role CHD7 plays in modifying downstream gene expression [217]. Two of these
identified binding sites are in the promoters of Sox11 and Sox4, which appears to be
required during adult neurogenesis in the hippocampus. In CHD7 mutant mice, there is a
decrease in the active histone marker H3K4 methylation at the Sox11 and Sox4
promoters in neural stem cells potentially as a direct result of the coordination of Chd7
with methyltransferase complexes [218] . In this CHD7 mutant the chromatin structure
remains closed, preventing the transcription of Sox11 and Sox4 and inhibiting
neurogenesis [208].
SOX4 and SOX11 are members of the group C family of SOX transcriptional
activators, whose name is derived from a shared DNA binding domain (the SRY-box)
originally identified in the mammalian sex-determining gene SRY [219]. SOX proteins
encode a large family of transcription factors that are grouped into individual families,
SOXA-SOXH, based on protein structure, expression, and conservation of amino acids.
Within individual families there is homology among the N-terminal DNA binding highmobility group (HMG) region, in addition to regions outside of this domain. The family of
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SOXC proteins also contains SOX12. All three genes are single exon genes that encode
two highly conserved domains, the HMG domain and a C-terminal transactivation
domain (TAD) [220]. The HMG domain enables specific DNA binding to the sequence
(A/T A/T CAA A/T) as well as nonspecific binding in the minor groove of DNA, which
induces DNA bending and makes regulatory regions such as promoters and enhancers
more accessible to other proteins [221–223]. These domains allow for transcriptional
control of downstream targets with the contribution of other regulatory proteins.
SOX proteins have been shown to regulate many developmental processes,
including early control of the establishment of blastocyst, gastrulation, and germ layers
as well as continued cellular pluripotency and cell fate and differentiation in tissue
formation and organogenesis [223–225]. More specifically, SOXC proteins have been
implicated in different aspects of neurogenesis including fate determination,
specification, migration, tract formation, and plasticity [226,227].
Interestingly, Sox4 and Sox11 are also expressed in neural crest cells during
development and are strongly expressed in purified neural crest cells from zebrafish
[228]. Moreover, Sox4- and Sox11-deficient animal models display coloboma, cardiac
malformations and brain defects like those seen in CHARGE syndrome [229–234]. In
addition, our lab has previously shown that Sox11 contributes to coloboma in zebrafish
and humans and another group has identified an individual with CHARGE with a
chromosomal duplication involving the SOX11 locus [234,235]. To better understand the
connection of CHD7 and Sox11 with respect to the ocular features of CHARGE
syndrome, further characterization of the contribution of these specific genes to ocular
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development and retinal neurogenesis must be elucidated, and the zebrafish is an
optimal model for this.

1.12 Zebrafish as a Model for studying ocular and retinal development
While this dissertation contains some studies of mouse tissue, much of the work
has been completed using the zebrafish model, Danio rerio. The zebrafish is a diurnal
teleost fish that has been widely used to study many biological processes, including
those involved in human disease. Specifically, zebrafish have many advantages when
utilized in the context of developmental disorders. They are externally fertilized and
have transparent and rapidly developing embryos. This along with the production of
large numbers of progeny allows for direct visualization of development processes in a
cost effective and highly efficient manner.
In addition, 70 percent of protein-coding human genes are related to genes
found in the zebrafish, and 84 percent of genes known to be associated with human
disease have a zebrafish counterpart [236]. Advances in genetic manipulations including
N-ethyl-N-nitrosourea (ENU) mutagenesis, morpholino knockdown, and genetic editing
using transcription activator-like effector nuclease (TALEN) and clustered regularlyinterspaced short palindromic repeats with Cas9 nuclease (CRISPR/Cas9) have further
developed the zebrafish as a model for human genetic disorders.
The specific genes of interest in CHARGE Syndrome (CHD7 and SOX11) have
zebrafish homologs and in fact zebrafish have two co–orthologs of mammalian Sox11,
sox11a and sox11b, which will be discussed further in Chapters 3 and 4. Finally, the
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developmental processes of interest in this dissertation, ocular morphogenesis and
retinal neurogenesis are highly conserved across vertebrates thus further making
zebrafish an attractive model for this work.
1.13 Rationale
CHARGE syndrome is a congenital disorder characterized by coloboma, heart
defects, choanal atresia, growth retardation, genital abnormalities, and ear
abnormalities. Pathogenic variants in CHD7 have been identified as the most common
genetic cause of CHARGE syndrome. However, work related to ocular development and
CHD7 has been limited and thus how these pathogenic variants result in ocular defects
and visual impairment are poorly understood. In addition, research in other sensory
tissues affected in CHARGE has identified a role for CHD7 in neurogenesis whereas
rigorous investigation into the role of Chd7 in the development of the retinal neurons
has been lacking. Furthermore, as a chromatin remodeler controlling expression of
downstream target genes, CHD7 likely regulates genes in eye development in a tissue
specific manner, but to date none of its target genes in the eye have been identified.
One possible target gene of CHD7 in ocular development is SOX11. Investigation into
SOX11 could help elucidate potential mechanisms leading to the observed ocular
phenotypes. Additionally, as a transcription factor itself, downstream targets of SOX11
in the eye have not been identified.
Considering these observations, we formulated several questions: Does CHD7
contribute to retinal development? If so, what are the potential retinal phenotypes
associated with the loss of CHD7? Do genetic mutants for Sox11 display ocular
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phenotypes relevant to CHARGE syndrome? Can we generate epitope-tagged knock-in
lines to facilitate further investigation of Sox11’s downstream targets?
In this dissertation, I used zebrafish and mouse animal models to answer these
questions. I characterized the expression pattern of CHD7 in the developing retina of
both the zebrafish and mouse. Additionally, I reported retinal cell defects in both the
zebrafish and mouse retina after the loss of Chd7. Further, I generated Sox11 mutant
zebrafish lines and preliminarily characterized CHARGE syndrome-like phenotypes.
Finally, I generated and validated an epitope tagged knock-in line for sox11a.
Together these studies provide the first evidence that Chd7 is required for
proper retinal development; furthermore, the mutant and knock-in lines I have
generated provide tools for future work to investigate the mechanisms leading to the
clinical phenotypes observed in developmental syndromes such as CHARGE.
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1.14 Specific Aims
I.

Investigate the role of Chd7 in zebrafish and mouse retinal development
a. Characterize the expression of Chd7 during retinal development
b. Characterize retinal photoreceptor differentiation and morphology by
immunohistochemistry in wild type and Chd7 mutant zebrafish and
mouse retina

II.

Generate an epitope tagged Sox11 transgenic zebrafish line
a. Characterize generation of knock-in line
b. Demonstrate expression of epitope tag

III.

Generate Sox11 knockout lines using CRISPR/Cas9
a. Characterize the induced genetic mutations
b. Preliminary characterization of mutant phenotypes

Aim I is addressed in Chapter 2
Aim II is addressed in Chapter 3 and the Appendix
Aim III is addressed in Chapter 4
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SEGMENT LENGTH
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2.1

Abstract
Mutations in the chromatin remodeling factor CHD7 are the predominant cause

of CHARGE syndrome, a congenital disorder that frequently includes ocular coloboma.
Although CHD7 is known to be required for proper ocular morphogenesis, its role in
retinal development has not been thoroughly investigated. Given that individuals with
CHARGE syndrome can experience visual impairment even in the absence of coloboma,
a better understanding of CHD7 function in the retina is needed. In this study, we
characterized the expression pattern of Chd7 in the developing zebrafish and mouse
retina and documented ocular and retinal phenotypes in Chd7 loss-of-function mutants.
Zebrafish Chd7 was expressed throughout the retinal neuroepithelium when retinal
progenitor cells were actively proliferating, and later in subsets of newly post-mitotic
retinal cells. At stages of retinal development when most retinal cell types had
terminally differentiated, Chd7 expression remained strong in the ganglion cell layer and
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in some cells in the inner nuclear layer. Intriguingly, strong expression of Chd7 was also
observed in the outer nuclear layer where it was co-expressed with markers of postmitotic cone and rod photoreceptors. Expression of mouse CHD7 displayed a similar
pattern, including expression in the ganglion cells, subsets of inner nuclear layer cells,
and in the distal outer nuclear layer as late as P15. Two different mutant chd7 zebrafish
lines were characterized for ocular and retinal defects. These mutants displayed
microphthalmia, reduced numbers of cone photoreceptors, and truncated rod and cone
photoreceptor outer segments. Reduced cone photoreceptor number and abnormal
outer segments were also observed in heterozygous Chd7 mutant mice. Taken together,
our results in zebrafish and mouse reveal a conserved, previously undescribed role for
Chd7 in retinal development and photoreceptor outer segment morphogenesis.
Moreover, our work suggests an avenue of future investigation into the pathogenesis of
visual system defects in CHARGE syndrome.

2.2

Introduction
Development of the vertebrate visual system requires the precise spatial and

temporal coordination of numerous gene regulatory networks and signaling pathways.
Early morphogenetic events lead to the formation of the optic cup and the structural
architecture of the eye; within the developing retina, this is followed by specification
and differentiation of the seven major retinal cell types in a largely conserved
spatiotemporal sequence. This complex process culminates in a highly organized neural

38

retina that is capable of capturing light and converting it into an electrical signal that
can then be transmitted to the brain and interpreted as an image.
Disruptions in eye development can result in congenital ocular malformations
such as microphthalmia, anophthalmia, and coloboma (collectively referred to as MAC),
as well as retinal cell defects, and are a significant cause of pediatric blindness
[237,238]. These ocular abnormalities often occur as a part of larger syndromic
disorders. One example is CHARGE syndrome, a genetic neural cristopathy
characterized by coloboma, heart defects, choanal atresia, growth retardation, genital
abnormalities, and ear abnormalities [130,133,134]. Based on clinical reports, coloboma
is present in over 80% of clinically diagnosed CHARGE syndrome patients[176].
However, CHARGE syndrome is also associated with other ocular complications,
including microphthalmia, optic nerve hypoplasia, nystagmus, cataracts, amblyopia,
microcornea, strabismus and rarely angle closure defects and retinal detachment [168–
170,172–176]. A recent study of visual function in 14 CHARGE syndrome patients found
that all had some degree of visual impairment, even in the absence of structural
malformations such as coloboma [178]. These results suggest that the visual system
disruptions associated with CHARGE syndrome may involve retinal developmental
defects in addition to problems with ocular morphogenesis.
Decades after the initial description of CHARGE syndrome, pathogenic variants in
the chromatin remodeling factor CHD7 were identified as the predominant genetic
cause [148–150]. CHD7 is a member of the chromodomain helicase-DNA binding
domain (CHD) family of proteins, initiating nucleosome remodeling that is essential for
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transcription at target loci [155]. CHD7 has been shown to work in a tissue-specific
manner to control target gene expression, by acting alone or as member of a complex
with other transcription factors [160,217,239].
CHD7 has also been shown to promote neurogenesis in many of the tissues
involved in CHARGE syndrome. Disruption of mouse CHD7 results in defects in the
development of specific sensory neurons in the auditory, vestibular, and olfactory
systems [205,206]. These data suggest that CHD7 may also play a role in the
development of sensory neurons in the retina, but studies specifically addressing this
question have been limited. One study used mouse conditional knockouts to delete
CHD7 from various embryonic tissues that contribute to the eye; this work
demonstrated that expression of CHD7 is required in the neural ectoderm for proper
ocular morphogenesis of the optic cup and optic fissure closure. Although the authors
also noted CHD7 expression in the developing mouse retina, the effects of loss of CHD7
on retinal neurogenesis were not extensively characterized [187]. General descriptions
of microphthalmia, coloboma, and anterior segment defects have been noted in
zebrafish models of Chd7 deficiency, but potential retinal phenotypes have not been
investigated [188,191,193]. One study using morpholino-mediated knockdown in
zebrafish observed gross retinal lamination defects upon loss of Chd7, indicating a
requirement for Chd7 in retinal organization [240]. Clearly, more in-depth studies are
needed to provide a better understanding of the pathogenetic mechanisms leading to
CHD7-associated ocular complications of CHARGE syndrome, and to determine whether
these include retinal differentiation defects.
40

In this study, we analyzed Chd7 expression in the developing retina and
investigated retinal phenotypes in zebrafish and mouse Chd7 mutants. We demonstrate
that in the zebrafish and mouse retina, Chd7 is expressed not only in early retinal
progenitor cells, but also later in subsets of differentiated retinal neurons, including
mature rod and cone photoreceptors. Importantly, we show that loss of Chd7 causes a
significant decrease in cone photoreceptor number and truncated photoreceptor outer
segments in both species. Taken together, this work suggests a novel, conserved role
for Chd7 in retinal development and photoreceptor outer segment morphogenesis.
2.3

Materials and Methods

2.3.1 Zebrafish Lines and Maintenance
Zebrafish were bred, raised, and housed at 28.5°C on a 14-hour light:10-hour
dark cycle in compliance with established protocols for zebrafish husbandry [241]. The
Tg(3.2TαC:EGFP) transgenic line (TαC:EGFP) has been previously described and was
generously provided by Susan Brockerhoff (University of Washington, Seattle, WA)
[242]. The Tg(XlRho:EGFP) transgenic line (XOPs:GFP) has been previously described
and was obtained from James Fadool (Florida State University, Tallahassee, FL) [243].
The chd7sa19732 mutant line was originally generated by the Zebrafish Mutation Project
at the Wellcome Sanger Institute [244] and was obtained from the Zebrafish
International Resource Center (ZIRC, Eugene, OR). Heterozygous chd7 adult CRISPR
mutants were provided by Jason Berman (Dalhousie University Halifax, Nova Scotia,
CA/Children's Hospital of Eastern Ontario Research Institute, Ottawa, Ontario, CA) [193].
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Wildtype zebrafish (AB strain) were obtained from the Zebrafish International Resource
Center (ZIRC, Eugene, OR). All animal procedures were carried out in accordance with
guidelines established by the University of Kentucky Institutional Animal Care and Use
Committee and the ARVO Statement for the Use of Animals in Ophthalmic and Vision
Research.
2.3.2 Zebrafish Genomic DNA extraction and amplification
Genomic DNA (gDNA) was extracted from whole embryos or tails. Tissue was
placed in 50mM sodium hydroxide and incubated at 95°C for digestion. The solution was
neutralized with 1 M Tris-HCl, pH 8.0. The gDNA was PCR amplified using primers
described in Supplemental Table 2.1. Products were visualized on 2% agarose gels and
successful amplification reactions were prepared for Sanger sequencing with Exo-CIP™
Rapid PCR Cleanup Kit according to the manufacturer’s protocol (New England Biolabs:
E1050S, Ipswich, MA). Samples were then sequenced with amplification primers
(Eurofins Genomics Services, Louisville, KY).
2.3.3 Mouse Lines and Maintenance
Chd7Gt/+ [182] (JAX stock 030659) mice were maintained by backcrossing
B6129SF1/J (JAX stock 101043) mice to N15. Timed pregnancies were established
between Chd7Gt/+ male mice and Chd7+/+ female mice from the colony. The day of plug
identification was designated as day 0.5. The day of birth was designated as P1. All
procedures were approved by The University of Michigan University Institutional Animal
Care & Use Committee (IACUC).
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Ear punches were collected from mice (P14-P21) and tail snips from
experimental embryos and pups. DNA was extracted using a HotShot method [245] and
samples were analyzed by PCR (primer sequences provided in Supplementary Table 1)
using cycling parameters designed by the Jackson Laboratory (Protocol 31768).

2.3.4 Mouse Tissue Preparation
Embryos (E15.5) and heads (skin removed E18.5 and P1) were dissected before
fixation in 4% PFA for 2h at room temperature. Specimens were washed three times in
1x PBS and transferred to 70% EtOH and dehydrated and embedded in paraffin wax
using a Tissue Tek (Torrance, CA) embedding machine. Paraffin embedded tissues were
stored at room temperature until sectioning. Eyes were enucleated from pups (P6, P10,
P15) as previously described [246]. Briefly, pups were anesthetized with CO2 and
euthanized by cervical dislocation. Skin around the eyes was snipped with dissecting
scissors to expose the eyes. Eyes were enucleated with preservation of the optic nerves
using Excelta 7-P1 curved forceps. Eyes were fixed in 4% PFA overnight at 4°C, then
washed in 1x PBS and incubated overnight in 10% followed by 30% sucrose at 4°C.

2.3.5 Western Blot
Protein lysate was extracted from a pool of 75 zebrafish heads collected from 3
dpf wildtype, heterozygous, and chd7 mutant zebrafish larvae in 1x RIPA buffer. Protein
was quantified on a BioSpectrometer (Eppendorf) with a Bradford Assay (Bradford
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Reagent-E530-1L). Protein lysate was diluted with an appropriate amount of 4x Loading
dye and incubated at 98˚C for 5 minutes. 20µg of each respective sample was loaded
onto a 1mm 3-8% Tris-Acetate Mini Protein gel (NuPAGE) along with 10µl of Spectra
Multicolor High Range protein ladder (Thermofisher). The gel was run at 80V for 15
minutes and then increased to 120V until the dye front reached the bottom. Wet
transfer onto a 0.2 µm nitrocellulose membrane (BioRad) was performed overnight at
4˚C with a stir bar and ice pack at 30mA for approximately 24hrs. The blot was then
blocked in 5% milk PBS-T for 2.5 hours at room temperature, and incubated with either
anti-CHD7 (1:500, Boster Bio DZ01533) or anti-Vinculin (1:2000, Boster Bio PA1781)
primary antibody in 0.5% milk PBS-T overnight at 4˚C on a shaker. The membrane was
washed 3 times for 5 minutes each with PBS-T on a shaker at room temperature. The
blot was resuspended in 0.5% milk PBS-T and incubated in anti-rabbit secondary
antibody (1:1000, Santa Cruz sc-2357) for one hour at room temperature. After
incubation, it was washed again 3 times for 5 minutes each with PBS-T on a shaker at
room temperature. The membrane was imaged on an Amersham Imager 680.
2.3.6 Immunohistochemistry
Zebrafish embryos were fixed overnight in 4% paraformaldehyde, then
incubated overnight in 10% followed by 30% sucrose at 4°C. 10 µm transverse zebrafish
and mouse cryosections were collected on a Leica CM1900 crysostat (Leica Biosystems,
Buffalo Grove, IL). 10 µm paraffin mouse sections were collected on a Thermo Scientific
Shandon Finesse ME Microtome (Thermo Scientific, Waltham, MA).
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Immunohistochemistry was performed on sections as previously described [247],
using the following primary antibodies: anti-zebrafish Chd7 (rabbit, 1:500; Boster
Bio:DZ01533, Pleasanton, CA); anti-mouse CHD7 (rabbit, 1:2500, Cell Signaling
Technologies:6505, Danvers, MA); 4C12, which labels zebrafish rod photoreceptors
(mouse, 1:100, J. Fadool, FSU, Tallahassee, FL); 1D1, which labels zebrafish rhodopsin
(mouse, 1:100, J. Fadool, FSU, Tallahassee, FL); Zpr-1, which labels zebrafish red-green
double cones (mouse, 1:20, ZIRC); Peanut agglutinin (PNA)-lectin conjugated to Cy5
(Vector Labs cl-1075, 1:1000); HuC/D (mouse, 1:20, Invitrogen, Grand Island, NY),
which labels retinal ganglion cells and amacrine cells; Prox1 (rabbit, 1:2,000,
Millipore, Billerica, MA), which recognizes horizontal cells; anti-PKCα (mouse, 1:100; cat.
no. sc-17769, SantaCruz Biotechnology), which labels bipolar cells; glutamine synthetase
(mouse, 1:500, BD Biosciences, Franklin Lakes, NJ) which labels Müller glia; anti-Blue and
anti-UV opsin antibodies (rabbit, 1:1,000), generously provided by D. Hyde (University of
Notre Dame); and 1D4, which labels mouse rhodopsin (Santa Cruz, sc-5743). Alexa
fluor conjugated secondary antibodies (Invitrogen, Grand Island, NY) and Cy-conjugated
secondary antibodies (Jackson ImmunoResearch, West Grove, PA) were used at
1:250 dilution. In addition, for anti-mouse Chd7, anti-mouse Chd7 primary antibody
was followed by signal amplification with goat anti-rabbit IgG horseradish peroxidase (1:
500) (Perkin Elmer Inc: NEF812001EA, Waltham, MA). The tyramide signal amplification
plus Cy3 Kit (1:1500) (Perkin Elmer Inc: NEL744001KT, Waltham, MA) was then used for
detection.
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Terminal deoxynucleotide transferase (TdT)-mediated dUTP nick end labeling (TUNEL)
was performed on frozen retinal cryosections using the ApopTag Fluorescein Direct In
Situ Apoptosis Detection Kit (Millipore, Billerica, MA). TUNEL staining was performed
according to the manufacturer’s protocol. For imaging, sections were counterstained
with 4′, 6-diamidino-2-phenylindole (DAPI, 1:10,000 dilution, Sigma-Aldrich). Images
were obtained on a Nikon Eclipse Ti-U inverted fluorescent microscope (Nikon
Instruments, Melville, NY) or a Leica SP8 DLS confocal microscope (Leica Microsystems,
Buffalo Grove, IL). For all experiments, at least 10 zebrafish embryos and 3 mouse
embryos/pups were analyzed per timepoint, and 3 separate biological replicates were
performed for each experiment.
2.3.7 Data Analysis and Figure Construction
All counts and measurements were performed on retinal cryosections containing
an optic nerve as a landmark. Zebrafish retina size and mouse retinal layers were
measured using ImageJ software (https://imagej.nih.gov/ij/). For zebrafish
photoreceptors, counts were obtained from three separate regions 100 mm wide: a
dorsal region 50 mm from the retinal margin, a central region 50 mm dorsal to the optic
nerve, and a ventral region 50 mm from the retinal margin. For mouse cone
photoreceptors, counts were obtained from two 500 mm-wide regions on either side of
the optic nerve. These counts were totaled. Statistics were conducted using two-factor,
unpaired t-test and one-way ANOVA using GraphPad software. P-values less than 0.05
were considered significant and are indicated by the following: *, p<0.05 ; **, p<0.01;
and ***, p<0.001. Boxplots were generated using the ggplot2 package in R (version
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3.6.2; https://www.R-project.org). All figures were constructed using Photoshop (Adobe
version 22.0.0).

2.4

Results

2.4.1 Chd7 Expression in Developing Retina
2.4.1.1 Chd7 is expressed in distinct subsets of differentiated retinal cell types.
To date there have been no published data on the expression of Chd7 in the
developing zebrafish retina. We investigated Chd7 expression using
immunohistochemistry (IHC) with an anti-zebrafish Chd7 antibody on retinal sections
taken at various timepoints during retinal development. At 24 and 48 hours post
fertilization (hpf), when retinal progenitor cells are still actively proliferating and the first
retinal ganglion and amacrine cells are becoming post-mitotic, Chd7 was broadly
expressed throughout the zebrafish retinal neuroepithelium (Fig. 2.1A-B). By 72 hpf,
when the majority of retinal cell types have exited the cell cycle and differentiated, Chd7
expression remained strong in the ganglion cell layer (GCL) and in cells in the basal
portion of the inner nuclear layer (INL), which are likely amacrine cells (Fig. 2.1C).
Interestingly, strong expression of Chd7 was also observed throughout the outer nuclear
layer (ONL) containing the cone and rod photoreceptor cell bodies. By 4 and 5 dpf, when
the zebrafish larvae display active swimming and visual behaviors (such as searching for
food and avoiding predators), Chd7 expression was reduced but still visible in the GCL
and inner INL, and remained strong in the photoreceptors of the ONL. Chd7 was also
continuously detected in the persistently neurogenic ciliary marginal zone (CMZ) at 3, 4,
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and 5 dpf (Fig. 2.1C-E). To investigate the ONL expression of Chd7 further, we
performed IHC for Chd7 on retinal sections from transgenic reporter lines that
fluorescently label cones and rods (TαC:GFP labels all cone photoreceptor subtypes;
XOPs:GFP labels rod photoreceptors). Chd7 expression significantly overlapped with
GFP-positive cone photoreceptors at 72 hpf and 5 dpf (Fig. 2.1F-G). In contrast, coexpression of Chd7 with GFP-positive rod photoreceptors was minimal at 72 hpf, but
was clearly present in rods by 5 dpf (Fig. 2.1H-I). Taken together, these results
demonstrate expression of Chd7 in retinal progenitor cells and a subset of fully
differentiated retinal neurons, including the photoreceptors.
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Figure 2.1 Chd7 is expressed in retinal progenitor cells and differentiated retinal cell types
in zebrafish.

Figure 2.1. Chd7 is expressed in retinal progenitor cells and differentiated retinal cell
types in zebrafish. (A-B) Broad expression of Chd7 is apparent in the developing retina
at 24 and 48 hours post fertilization (hpf).I) At 72 hpf, Chd7 is expressed throughout
ganglion cell layer (GCL), some cells of inner nuclear layer (INL), sporadic cells of outer
nuclear layer (ONL), and the ciliary marginal zone (CMZ). (D-E) Chd7 expression at 4 and
5 days post fertilization (dpf) shows reduction in GCL and INL expression and strong ONL
expression. (F-G) At 72 hpf (F) and 5 dpf (G) Chd7 co-localizes with GFP-positive cone
photoreceptors marked by the TαC:GFP transgene. IHC for Chd7 in the XOPs:GFP
transgenic line which fluorescently labels rod photoreceptors demonstrates that Chd7
has minimal co-expression with rod photoreceptors at 72 hpf (H) and increased coexpression at 5 dpf (I). Arrows indicate Chd7 expression in the ONL. ONL, outer nuclear
layer; INL, Inner nuclear layer; GCL, ganglion cell layer; L, lens; CMZ, ciliary marginal
zone; D, dorsal; V, ventral; R, retinal neuroepithelium; hpf, hours post fertilization; dpf,
days post fertilization. Scale bars, 10µm in F-I and 50µm in A-E.

2.4.1.2 Mouse retinal CHD7 expression is similar to that of zebrafih.
[182] To determine whether CHD7 demonstrates similar expression patterns in
the developing mouse retina, we performed IHC on mouse retinal sections at various
embryonic and postnatal stages. CHD7 was expressed throughout the inner neuroblastic
49

layer (INBL) in the developing mouse retina at embryonic day 15.5 when retinal
progenitors are actively proliferating, and early cells of the retina are beginning to
differentiate (Fig 2.2A). At E18.5 CHD7 expression was detectable in the newly formed
ganglion cell layer (GCL), and CHD7 expression remained strong in the GCL at all
subsequent timepoints (Fig. 2.2B-F). Sporadic expression of CHD7 was observed
throughout the inner and outer neuroblastic layers (ONBL) at E18.5 and P1 (Fig. 2.2B-C).
At P6, when retinal lamination was complete, CHD7 expression was prominent in the
inner part of the INL but was not detectable in the ONL (Fig. 2.2D). This INL expression
remained strong at P10 (when retinal progenitors are no longer present), and faint
CHD7 expression also became evident in sporadic cells of the ONL (Fig. 2.2E).
Interestingly, at P15 (just after eye opening) CHD7 expression remained strong in the
GCL, numerous cells of the INL and was prominent in the distal portion of the ONL (Fig.
2.2F). The specificity of the CHD7 antibody signal was validated by observing expression
in the Chd7Gt/+ gene-trap mutant mouse line [182], which demonstrated a markedly
reduced signal at E15.5 and P15. The mouse expression data, along with the zebrafish
expression pattern, suggests a conserved novel role for CHD7 in retinal progenitor cells
and retinal neurogenesis and a previously undescribed expression and role in fully
differentiated retinal cells.
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Figure 2.2 Chd7 is expressed in retinal progenitor cells and differentiated retinal cell types
in mouse.

Figure 2.2 Chd7 is expressed in retinal progenitor cells and differentiated retinal cell
types in mouse. (A) Chd7 expression is strong in the inner neuroblastic layer (INBL) at
E15.5 (B) At E18.5, Chd7 expression continues in the INBL and is observed in sporadic
cells of the outer neuroblastic layer (ONBL). (C-F) Chd7 expression at postnatal days P1,
P6, P10, and P15. At P1 (C) expression is strong in the ganglion cell layer (GCL) and
throughout the inner nuclear layer (INL) and ONBL. At P6 and P10 (D-E), Chd7
expression becomes restricted to the GCL and inner cells of the INL, and expression
begins in a few cells of outer nuclear layer (ONL). By P15 (F), Chd7 expression remains
strong in ganglion cell layer, cells of inner nuclear layer, and in a band of cells in the
distal ONL. (G-H) Chd7 expression is significantly decreased in Chd7Gt/+ mutant mice at
E15.5 and P15. Arrows indicate expression in presumptive photoreceptor cells of the
ONL. ONL, outer nuclear layer; INL, Inner nuclear layer; GCL, ganglion cell layer; ONBL,
outer neuroblastic layer; INBL, inner neuroblastic layer. Scale bar is 100 µm for all
panels.
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2.4.1.3 CHD7 is expressed in the developing and mature human retina.
To determine whether CHD7 is expressed in the developing and adult human
retina, we searched two publicly available data meta-analysis platforms. Using the
eyeIntegration v1.05 platform which collates human eye tissue RNA-seq data with other
human body tissues [215] , CHD7 was shown to be globally expressed in fetal human
retina and postnatal retina at levels equal to that of the cerebellum (Fig. S2.1A). Using
the online PLatform for Analysis of scEiad (Single Cell Eye in a Disk) [248], we generated
an in-situ projection of CHD7 expression in human adult retina, which indicates highest
CHD7 expression in cones, rods, and retinal ganglion cells with lower expression in
Müller glia (Fig. S2.1B). In addition, when including data from fetal human retina and
retinal organoids, expression of CHD7 was detected in early and late retinal progenitor
cells including photoreceptor precursors (Supplementary Table 2.2). These expression
data, together with our zebrafish and mouse IHC results, strongly suggest a conserved
role for CHD7 in retinal development across vertebrates.
2.4.2 Gross morphology of zebrafish chd7 mutants
2.4.2.1 Characterization of zebrafish chd7 mutant alleles
To further explore the role of chd7 in retinal development we obtained two
different zebrafish mutant lines. The first line is a previously uncharacterized N-ethyl-Nnitrosourea (ENU) mutant generated by the Zebrafish Mutation Project at the Wellcome
Sanger Institute (obtained from ZIRC – sa19732). This allele contains a point mutation in
the helicase domain of Chd7 resulting in a premature stop codon and predicted
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truncated mutant protein of 1449 amino acids (compared to wildtype length of 3140
amino acids) (Fig. 2.3A). We confirmed loss of Chd7 protein expression in this line via
western blot, which revealed a decrease in Chd7 expression in heterozygous animals
and complete loss of Chd7 protein expression in homozygous mutant animals (Fig. S2A).
The second mutant line is a previously characterized CRISPR mutant with a 2-bp deletion
in exon 2 of chd7, resulting in a frameshift and early termination codon, and a predicted
protein of only 43 amino acids (Cloney et al., 2018). CHARGE-relevant phenotypes
previously described in this mutant line include pericardial edema, microphthalmia,
abnormal curvature of the spine and cardiac and gastrointestinal defects [193].

2.4.2.2 Zebrafish chd7 mutants display phenotypes observed in CHARGE syndrome.
We first characterized the gross morphology of the chd7sa19732 mutant compared
to the previously described CRISPR mutant using light microscopy of progeny from
heterozygous in-crosses. At 5 dpf we observed a lack of swim bladder inflation,
pericardial edema, microphthalmia, and craniofacial abnormalities in both the
homozygous CRISPR mutant and the chd7sa19732 mutant compared to wildtype and
heterozygous larvae (Fig. 2.3B). At 14 dpf, both the homozygous chd7sa19732 and CRISPR
mutants remained significantly smaller than their heterozygous and wildtype siblings,
and continued to display a smaller swim bladder, craniofacial, and spinal deformities
(Fig. 2.3C). We also preformed intercrosses between the chd7sa19732 and CRISPR mutants
and observed similar phenotypes in compound heterozygotes (data not shown). We
noticed a significant decrease in homozygous mutant survival, with only 13% of chd7-/53

larvae surviving to adulthood (Fig. 2.3D). Nevertheless, the surviving adult homozygous
mutants were fertile, and crosses of chd7 mutant females and males produced clutches
of chd7 mutant offspring. The maternal zygotic chd7 mutant progeny (from the
chd7sa19732 mutant line) displayed more severe pericardial edema, microphthalmia, and
craniofacial abnormalities than the zygotic mutants (Fig. 2.3B). Furthermore, when
homozygous mutant females were crossed with heterozygous males, heterozygous
progeny displayed phenotypes similar to their homozygous mutant siblings, suggesting
that the presence of maternal chd7 mitigates the phenotypes of zygotic mutants. Due to
the low numbers of homozygous chd7 mutants that survive to adulthood, we
characterized chd7 zygotic mutants for the majority of this study.
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Figure 2.3 chd7 mutant zebrafish display gross morphological defects and decreased
survival.

Figure 2.3. chd7 mutant zebrafish display gross morphological defects and decreased
survival. (A) Schematic of wildtype and predicted chd7sa19732 and CRISPR mutant
proteins with indicated protein domains. The chd7sa19732mutant protein is predicted to
be 1449 aa and CRISPR mutant protein is predicted to be 43 aa compared to wild type
length of 3140 aa. (B) chd7 mutants display craniofacial, swim bladder, and pericardial
abnormalities at 5 dpf compared to wildtype. (C) Gross morphology of WT and chd7
mutants at 14 dpf; chd7 mutants continue to display morphological defects and are
smaller in size. Black asterisks indicate pericardial edema; red asterisks indicate lack of
or smaller swim bladder. Red arrows indicate craniofacial abnormalities. (D) Proportion
of surviving mutants at two months shows less than the expected 25% of homozygous
mutants.
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2.4.2.3 Loss of Chd7 results in microphthalmia.
We next investigated overall retinal structure of chd7 mutants at 5 dpf. Using
retinal cryosections immunolabeled with the anti-Chd7 antibody along with nuclear
staining, we observed a decrease of Chd7 expression in the retina of heterozygous chd7
mutants, and confirmed complete loss of Chd7 expression in homozygous mutants at 5
dpf (Fig. 2.4A-F). We observed no significant defects in laminar organization nor
evidence of retinal coloboma in either chd7 mutant line at this stage. However, both
CRISPR and chd7sa19732 mutants were microphthalmic; we quantified relative eye size by
measuring the retinal perimeter and normalizing that to the nose-to-otolith length to
account for any gross larval size differences across genotypes. In both the CRISPR and
chd7sa19732 mutants, there was a significant difference between the normalized wildtype,
heterozygous, and homozygous eye sizes (p<.05); homozygous mutants displayed the
most severe reductions in eye size (p<.01 in the chd7sa19732 mutant and p<.001 in the
CRISPR mutant), suggesting an additive effect of each mutant allele on this phenotype.
(Fig. 2.4G). This change in retinal size was also observed in the heterozygous Chd7 mice,
where there was a significant difference in the width of both the inner nuclear layer and
outer nuclear layer compared to wildtype (Fig. S2.3A). These results suggest that loss of
Chd7 in zebrafish results in microphthalmia but not coloboma (in zebrafish),
recapitulating some of the ocular malformation defects observed in CHARGE syndrome.
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Figure 2.4 chd7 mutants lack retinal Chd7 expression and display microphthalmia.

Figure 2.4. chd7 mutants lack retinal Chd7 expression and display microphthalmia. (AC). Chd7 expression in wild type, chd7 heterozygous, and chd7 homozygous mutant of
chd7sa19732 mutant line (D-F). Chd7 expression in wild type, chd7 heterozygous, and chd7
homozygous mutant of CRISPR mutant line. Both lines showed decreased Chd7
expression in heterozygotes and a lack of Chd7 expression in homozygotes. (G) Chd7
mutants have microphthalmia compared to wildtype zebrafish. Measurements taken
from perimeter of retina normalized to nose to otolith length. (*p < 0.05, **p< 0.01,
***p< 0.001). ONL, outer nuclear layer; INL, Inner nuclear layer; GCL, ganglion cell layer;
L, lens; D, dorsal; V, ventral. Scale bar 50 µm.

57

2.4.3 Specific retinal cell defects in chd7 zebrafish mutants
2.4.3.1 chd7 mutants display a decrease in cone but not rod photoreceptors
Because we observed strong expression of Chd7 in newly differentiated
photoreceptors, we next wanted to determine whether loss of Chd7 resulted in any
photoreceptor phenotypes. We quantified the number of rod and cone photoreceptors
in wildtype and chd7 CRISPR mutants at 5 dpf by IHC, using the Zpr1 antibody (which
labels red-green double cones) and 4C12 (which detects rods) [249]. In wildtype retinas,
we observed a compact and continuous layer of red-green cones in the ONL at 5 dpf
(Fig. 2.5A-A’). However, in chd7 heterozygous and homozygous mutant retinas we
observed gaps in double cone spacing across the entire ONL (Fig. 2.5B-C, Fig. 2.5B’-C’).
We quantified red-green double cone density by counting the number of Zpr1-labeled
cells within three 100 µm regions: the dorsal retina (50 µm from the dorsal CMZ),
central retina (50 µm dorsal to the optic nerve), and ventral retina (50 µm from ventral
CMZ). This quantification confirmed that red-green cones are significantly reduced in
both heterozygous and homozygous chd7 mutants compared to wildtype retinas (52+/4 in wt vs. 41+/-4 in chd7 heterozygotes and 33+/-3 in chd7 homozygous mutants;
p<.001 for both comparisons; n=10 per genotype; Fig. 2.5G). Interestingly, we did not
observe a similar reduction in rod photoreceptors in chd7 mutants at this stage (Fig. 5DF’, H). We confirmed that the loss of cones was not unique to the CRISPR chd7 mutant
by conducting the same IHC experiments in the chd7sa19732mutant. These mutants had a
similar gap in red-green cones in the ONL compared to their wildtype siblings (Fig.
S2.4A-C, A’-C’), although the reduction was smaller than that observed in the CRISPR
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mutant (Fig. S2.4G). As with the CRISPR mutants, rod photoreceptor number in the
chd7sa19732 mutant was not significantly reduced compared to wild type retinas (Fig.
S2.4D-F, D’-F’, and Fig. S2.4H). Taken together, these results demonstrate that the loss
of Chd7 causes a significant decrease in cone, but not rod, photoreceptor number.
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Figure 2.5 chd7 mutant zebrafish have fewer cone photoreceptors.

Figure 2.5. chd7 mutant zebrafish have fewer cone photoreceptors. (A-C)
Immunohistochemistry with a red-green cone antibody (Zpr1) in chd7+/+ (A,A′), chd7+/(B,B′), and chd7-/- (C,C′) retinal sections. Arrows indicate missing red-green cone
photoreceptors. (D-F) Immunohistochemistry with a rod antibody (4C12) in chd7+/+
(D,D′), chd7+/- (E,E′), and chd7-/- (F,F′) retinal sections. (G) Quantification confirms a
decrease in red/green cones in chd7+/- and chd7-/- larvae compared to chd7+/+. (Number
of cones per 300 uM; ANOVA followed by t-test ;***p <.001). (H) No significant
difference in rod photoreceptors between in chd7+/+, chd7+/-, and chd7-/- larvae (Number
of rods per 300 uM). ONL, outer nuclear layer; INL, Inner nuclear layer; GCL, ganglion
cell layer; L, lens; ON, optic nerve; D, dorsal; V, ventral. Scale bars 25 µm in A’-F’ and 50
µm in A-F.

2.4.3.2 Cone and rod outer segments display truncation in chd7 mutant.
In addition to the reduced numbers of cones, we noticed a decrease in antibody
labeling of the photoreceptor outer segments in chd7 mutants. To further investigate
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this, we specifically labeled rod and cone outer segments using the 1D1 antibody for rod
outer segments [243] and peanut agglutinin (PNA) for cones [250]. Whereas in 5 dpf
wildtype retinas, we observed elongated rod outer segments that intercalated with the
retinal pigment epithelium (RPE), in both the heterozygous and homozygous chd7
mutants rod outer segment length appeared severely reduced (Fig. 2.6A-C). We
quantified this reduction by averaging the length of 1D1-positive outer segments from
10 rods per eye in a minimum of 30 larvae of each genotype; this analysis confirmed a
significant difference between wildtype and mutant rod outer segment length (14.4+/0.86 µm in wt vs. vs. 6.6+/-0.47 µm in chd7 heterozygotes and 5.6+/-0.25 µm in chd7
null mutants; p<.001 for both comparisons; n=30 for each genotype; Fig. 2.66G).
Similarly, we observed a significant decrease in the length of PNA-positive cone outer
segments of chd7 heterozygotes and homozygous mutants, with the truncation
appearing most severe in chd7 -/- retinas (Fig. 2.6D-F). Quantifying the length of PNApositive cone outer segments across genotypes revealed a reduction in outer segment
length of 45% in heterozygous and 66% in homozygous chd7 mutant cones compared to
wild type (7.6+/- 0.31 µm in wt vs. 4.1+/-2.5 µm in chd7 heterozygotes and 2.6+/-0.26
µm in chd7 mutants; p<.001 for both comparisons; n=30 for each genotype; Fig. 2.6H).
To determine whether all zebrafish cone subtypes were affected by the loss of Chd7, we
performed immunohistochemistry with UV and blue cone opsin-specific antibodies. We
observed similar reductions in blue and UV cone outer segments in chd7+/- and chd7-/retinas compared with wild type retinas (Fig S2.5A-F). To evaluate whether the
photoreceptor phenotypes persisted beyond the larval stage of development, we
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observed retinas of wildtype and chd7 mutant larvae at 14 dpf. We detected similar
photoreceptor phenotypes in chd7 mutant retinas at this stage, including fewer redgreen cones and truncated cone and rod outer segments (Fig. S2.6A-J). Taken together,
these results demonstrate that that loss of Chd7 disrupts outer segment morphogenesis
or maintenance in all zebrafish photoreceptors, and these defects persist into the
juvenile stage.

Figure 2.6 chd7 mutant zebrafish display truncated photoreceptor outer segments

Figure 2.6. chd7 mutant zebrafish display truncated photoreceptor outer segments. (AC) Immunohistochemistry with a rhodopsin antibody (1D1) in chd7+/+ (A), chd7+/- (B), and
chd7-/- (C) retinal sections. (D-E) PNA labeling of cone outer segments in chd7+/+(D),
chd7+/-(E), and chd7-/- (F) retinal sections. (G) Average rod outer segment length in
chd7+/- and chd7-/- larvae is +/+ significantly decreased compared to chd7 . (H) Cone outer
segments also display a significant decrease in length in chd7+/- and chd7-/- larvae
compared to chd7+/+ larvae. Each data point represents the average measurement for an
individual eye, with a minimum of 10 cells measured per eye. Brackets represent region
of length measurement for individual outer segments. (*p < 0.05, **p< 0.01, ***p<
0.001). ONL, outer nuclear layer. Scale bar, 15 μm.
62

2.4.3.3 Other retinal cell types are unaffected in chd7 CRISPR mutants
To determine if the loss of Chd7 affects other retinal cell types we performed
immunohistochemistry with cell-type specific antibodies for ganglion cells, amacrine
cells, bipolar cells, horizontal cells, and Müller glia at 5 dpf. Using HuC/D (ganglion and
amacrine cells), PKC𝑎𝑎 (bipolar cells), Prox1 (horizontal cells), and glutamine synthetase
(Müller glia), we observed that all cell types were present and there was no obvious
decrease in number or morphology of cells in chd7 mutant retinas compared to wildtype
retinas (Fig. S2.7A-L). While more subtle differences may be identified with further
examination, these results suggest that the loss of Chd7 has the strongest impact on the
number and morphology of photoreceptors.

2.4.3.4 Apoptosis is not increased in chd7 mutant retinas at 5 dpf.
To determine whether the reduced numbers of cone photoreceptors in chd7
mutants are the result of a decrease in their survival, we performed TUNEL labeling on
retinal cryosections at 5 dpf in wildtype and chd7 CRISPR zebrafish mutants to identify
apoptotic cells. We observed no significant difference in number of TUNEL+ cells
between retinal sections of wildtype and mutant larvae (Fig. S2.8A-C). While we cannot
exclude the possibility that loss of Chd7 causes apoptosis in the retina at earlier
developmental timepoints, this result suggests that cone photoreceptors of chd7
mutants are not reduced via cell death at this stage.
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2.4.3.5 Maternal zygotic chd7 mutants display more severe photoreceptor defect.
Given the more severe gross morphological defects detected in maternal zygotic
(MZ) chd7 zebrafish mutants, we were interested in determining whether the eye size
and photoreceptor defects were also more severe in chd7 MZ mutants. Using the same
morphometric and immunohistochemical methods as described above, we detected a
significant decrease in eye size in chd7 MZ mutants compared to zygotic mutants (Fig.
S2.9E). We also found that MZ mutants have fewer red-green cones than zygotic
mutants (Fig. S2.9A-A’), but the number of rod photoreceptors was again not
significantly different (Fig. S2.9C-D, Fig. S2.9G). Taken together, this indicates that
maternal Chd7 not only contributes to ocular morphogenesis and growth but is also
important for photoreceptor development.

2.4.4 Chd7Gt/+ mouse mutants display loss of cone photoreceptors and truncated rod
and cone outer segments
Finally, to investigate whether CHD7 is required for proper photoreceptor
development in a mammalian model, we examined photoreceptor number and outer
segment morphology in Chd7Gt/+ retinas. We used the 1D4 antibody to detect rhodopsin
and PNA to label cone photoreceptor outer segments. At P6, when retinogenesis is
complete in the central retina and outer segments are beginning to mature, we
observed nascent rod and cone outer segments in both wildtype and Chd7Gt/+ mouse
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retinas, although there were fewer PNA-positive cells in the Chd7Gt/+ retina (Fig. 2.7A-D).
By P15, we detected shorter rod outer segments in the Chd7Gt/+ retina, and no
discernable difference in rod density (Fig. 2.7E-F). For the cone photoreceptors, we
detected a significant (40%) reduction in the number of cones in Chd7Gt/+ retinas, based
on total counts obtained from two 500 µm regions on either side of the optic nerve and
excluding regions with evident coloboma (83 +/- 2 cones in wt vs. 50+/- 5 in Chd7Gt/+;
n=3 per genotype; p<.001; Fig. 2.7G-I). Chd7Gt/+ cone outer segment length was also
reduced relative to wild type cones. Overall, these results suggest that Chd7 has a
conserved role in photoreceptor development and outer segment morphogenesis.
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Figure 2.7 Chd7 heterozygous mutant mice have fewer cones and truncated outer
segments.

Figure 2.7. Chd7 heterozygous mutant mice have fewer cones and truncated outer
segments. (A-D) Immunohistochemistry with rhodopsin antibody (1D4) in Chd7+/+ and
Chd7Gt/+ P6 and P15 retinal sections. (E-H) PNA labeling in Chd7+/+ and Chd7Gt/+ P6 and
P15 retinal sections. Brackets indicate region of outer segments, which are shorter in
Chd7Gt/+ retinas. (I) Quantification of cone cell number shows a significant decrease in
Chd7Gt/+ compared to Chd7+/+ at P15 (number of cones per 1000 µm , ***p <.001). ONL,
outer nuclear layer. Scale bar, 25 μm.
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2.5

Discussion
Most studies on the ocular complications of CHARGE syndrome have focused on the

early ocular morphogenesis defects – microphthalmia, coloboma, and optic nerve
anomalies – that are associated with this disorder [187,239]. Given that CHD7 has a
demonstrated, critical role in neurogenesis in the CNS as well as in auditory and
olfactory sensory neurons [205–207,251], it is important to investigate whether CHD7
also contributes to the development of retinal neurons.
In this study, we demonstrated that Chd7 is expressed in zebrafish and mouse
retinal progenitor cells, as well as in the persistently neurogenic ciliary marginal zone of
the zebrafish retina. These expression data are in line with previously reported roles of
CHD7 in neurogenesis. CHD7 and its chromatin remodeling function have been
implicated in both the central and peripheral nervous systems. In the central nervous
system, CHD7 has been shown to promote development of neurons in the brain, cortex,
and cerebellum and in the neural stem cells of the subventricular zone (SVZ) of the
lateral ventricle (LV) and the subgranular zone (SGZ) of the dentate gyrus (DG) in the
adult hippocampus [208,252]. In the peripheral nervous system, disruption of CHD7
leads to defects in neuron development of the olfactory and auditory system [205,206].
Furthermore, loss of CHD7 in mouse embryonic stem cells results in defects in neuron
differentiation including disrupted neuronal complexity and length as a consequence of
disturbed expression of pro-neural genes [213]. Our studies suggest CHD7 may have a
similar role in the specification and differentiation of various cell types in the retina.
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We also found that CHD7 is expressed in terminally differentiated retinal cells in
zebrafish, mouse, and humans, including ganglion cells, amacrine cells, and
photoreceptor cells. To our knowledge, this expression pattern in post-mitotic retinal
neurons has not been previously described and suggests that CHD7 has important
functions in these newly differentiated cell types that bears further investigation.
In zebrafish and mouse models of CHD7 deficiency, we observed previously reported
phenotypes of craniofacial defects, heart defects, and microphthalmia – all phenotypes
relevant to CHARGE syndrome [182,190–193]. Interestingly, although coloboma was
evident in mouse Chd7 heterozygotes, we did not observe coloboma in either of the
zebrafish mutant lines. This lack of coloboma in the zebrafish mutants could be due to
expression of wildtype maternally provided chd7 mRNA in zygotic mutants; however,
this seems unlikely since there were no colobomas in chd7 maternal zygotic mutants. It
is possible that the rapid window of ocular morphogenesis in zebrafish compared to
mammals allows for optic fissure closure to occur without deleterious effects of Chd7
loss in the developing eye. However, zebrafish chd7 mutants display microphthalmia,
suggesting that loss of Chd7 does have negative consequences even at early stages of
zebrafish eye development. Alternatively, there may be another Chd family member
(such as Chd5, which is expressed in the eye) that can compensate for the loss of Chd7
in zebrafish with respect to optic fissure fusion [253,254]. It is also possible that the
molecular mechanism of choroid fissure closure is different between species, with Chd7
being required for certain steps of this process in the mouse but not in zebrafish.
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One of the most intriguing findings of our study is that in both zebrafish and mouse
Chd7 mutants, we observed previously unreported photoreceptor phenotypes. These
phenotypes include a significant decrease in cone photoreceptors and truncation of
outer segments in both rod and cone photoreceptors. It is important to note that these
retinal phenotypes were present in heterozygous as well as homozygous chd7 mutants.
The CRISPR mutant line used in our study was also previously reported to display
gastrointestinal motility defects in both heterozygous and homozygous mutants. Taken
together, these results suggest that loss of Chd7 in zebrafish results in haploinsufficient
phenotypes similar to human CHARGE syndrome [193], and the eye phenotypes further
establish zebrafish as a model to investigate the pathogenesis of CHARGE syndromeassociated ocular defects.
Outer segments are essential for the phototransduction process, and thus are vital
for vision. Given the lack of elongation of rod and cone outer segments in Chd7 mutants
of both zebrafish and mice, we predict that CHD7 plays a role in the development
and/or maintenance of the unique photoreceptor outer segment structure.
Photoreceptor outer segments, also known as photoreceptor cilia, are similar to other
non-motile cilia and require many of the same abundant proteins for structure and
function [255]. Chd7Gt/+ mice have previously been reported to have inconsistent and
patchy labeling of olfactory cilia compared to wildtype mice [206]. Taken together, we
hypothesize that CHD7 may be required for the expression of one or multiple cilia genes
and perhaps those that are essential for length of cilia or outer segment disk
morphogenesis. Recently, CHD7 was also suggested to play a protective role in the
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auditory neurons and hair cells of the ear, and loss of CHD7 leads to oxidative stressinduced degeneration and sensorineural hearing loss [216]. Given that hair cells and
photoreceptors are both highly metabolically demanding sensory neurons, CHD7 could
also be playing a role in oxidative stress response in photoreceptors. In future work it
will be important to determine whether loss of CHD7 increases oxidative stress in the
retina, and whether the altered outer segment morphology in CHD7 mutant
photoreceptors results in reduced visual responses.
Although the expression pattern of CHD7 in the retina and photoreceptor
phenotypes observed with loss of CHD7 strongly suggest that CHD7 is important for
photoreceptor differentiation, to our knowledge photoreceptor defects have not yet
been identified in individuals with CHARGE syndrome. This could be a result of the
multifaceted nature of the other ocular malformations observed with CHD7 mutations.
The visual impairments resulting from coloboma, in addition to the complex clinical
presentation of CHARGE syndrome, makes it challenging to perform normal vision
assessments, potentially masking any accompanying retinal dystrophy. Moreover,
photoreceptor defects may take years to become evident, and long-term studies on
visual acuity in adults with CHARGE syndrome have not been reported. A recent study of
visual function in 14 children with CHARGE syndrome found that all had some degree of
visual impairment, even in the absence of structural malformations such as coloboma
[178]. These results suggest that the visual system disruptions associated with CHARGE
syndrome may indeed involve retinal cell type defects in addition to problems with
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ocular morphogenesis. Thus, more work and novel assessments may be necessary for
individuals with CHARGE to identify potential underlying retinal cell pathology.
In conclusion, we have identified and characterized a novel expression pattern and
role for CHD7 in retinal development. Future studies will help to identify the molecular
targets of CHD7 in the developing retina and in newly differentiated photoreceptors,
which should help to clarify the role of Chd7 in outer segment morphogenesis and
maintenance. Taken together, our results suggest an important avenue of future
investigation on the pathogenesis of visual system defects in CHARGE syndrome.
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2.6

Supplemental Tables

Table S2.2.1 PCR and Sanger Sequencing primers used in this study

Line
chd7sa19732 F

Sequence

Use

CCCTCAAAATGACCTGCAGGTAAGCATGC PCR/Sequencing

chd7sa19732 R

TTCATACCCCATTGGCAGCATTCTCCCT

PCR/Sequencing

chd7 CRISPR F

GAGCACACATTCCCTGTCCT

PCR/Sequencing

chd7 CRISPR R

AGGACATGCCATTCACTGGT

PCR/Sequencing

Chd7 Mouse WT R

GCAGGCAAGCAGATGTATGA

PCR

Chd7 Mouse Common

CAAGCTCGCTTTTCAACCTC

PCR

Chd7 Mouse Mutant R

ACTTGTGGTCTCGCTGTTCC

PCR
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Table S2.2.2 Cellular expression data for CHD7 from PLatform for Analysis of scEiad
(Single Cell Eye in a Disk)

Predicted Cell Type

Cells # Detected

Total
Cells

Cone

3226

7854

41.07

0.49

Late RPC

755

1762

42.85

0.43

RPC

11834

31803

37.21

0.43

Neurogenic Cell

1438

3300

43.58

0.4

Retinal Ganglion
Cell

7338

19815

37.03

0.4

Photoreceptor
Precursor

948

2621

36.17

0.37

Rod

23340

80847

28.87

0.34

Corneal Nerve

104

376

27.66

0.32

Muller Glia

9719

35813

27.14

0.31

Blood Vessel

2331

9744

23.92

0.29
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%

log2(counts+1)

2.7

Supplemental Figures

Figure S 2.1 CHD7 is expressed in cells of developing and adult human retina

Figure S2.1. CHD7 is expressed in cells of developing and adult human retina. (A) Box
plot of pan-Human CHD7 expression in fetal and adult retinal tissue (red box) compared
to other tissues including cerebellum (blue box). Assembled with eyeIntegration v1.05
platform [215]. (B) In-situ projection from published human single cell RNAseq datasets.
Assembled with PLatform for Analysis of scEiad [248]. Expression is highest in cones,
rods, and retinal ganglion cells with lower expression in Müller glia.
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Figure S 2.2 Loss of Chd7 protein expression in chd7 ENU mutant

Figure S2.2 Loss of Chd7 protein expression in chd7sa19732 mutant. Western blot of
chd7+/+, chd7+/-, chd7-/- embryo lysate. Full-length Chd7 is 349 kDa. Lower blot is
Vinculin loading control.
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Figure S 2.3 Retinal layers are smaller in Chd7 Gt/+ mutant mice compared to wild type

Figure S2.3. Retinal layers are smaller in Chd7 Gt/+ mutant mice compared to wild type.
Width of inner and outer nuclear layer measurements between Chd7Gt/+ mutant mice
and Chd7+/+ mice at P15 demonstrate significant decrease in Chd7 heterozygous
mutants. (t-test; n=3; ***p< 0.001).
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Figure S 2.4 chd7sa19732 mutant zebrafish have less cone photoreceptors

Figure S2.4. chd7sa19732 mutant zebrafish have less cone photoreceptors.
Immunohistochemistry with a red-green cone antibody (Zpr1) in chd7+/+ (A,Aʹ), chd7+/(B,Bʹ), and chd7-/- (C,Cʹ) retinal sections. Arrows indicate missing red-green cone
photoreceptors. (D-F) Immunohistochemistry with a rod antibody (4C12) in chd7+/+
(D,Dʹ), chd7+/- (E,Eʹ), and chd7-/- (F,Fʹ), retinal sections. (G) Quantification showed
decrease in red/green cones in chd7+/- and chd7-/- larvae compared to chd7+/+ (number of
cones per 300 μm; ANOVA followed by t-test ; n=10; ***p <.001). (H) Quantification
showed no difference in rod photoreceptors between in chd7+/+, chd7+/-, and chd7-/larvae (number of rods per 300 uM). ONL, outer nuclear layer; INL, Inner nuclear layer;
GCL, ganglion cell layer; L, lens; ON, optic nerve; D, dorsal; V, ventral. Scale bars 25 µm
for A’-F’ and 50 µm for A-F.
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Figure S 2.5 chd7 CRISPR mutant zebrafish have reduced UV and blue cones

Figure S2.5. chd7 CRISPR mutant zebrafish have reduced UV and blue cones.
Immunohistochemistry using a blue (A–C), and UV (D–F) cone opsin antibody on chd7 ,
chd7 , and chd7-/- retinal cryosections shows a similar loss of UV and Blue cones as for
red and green cones (Fig. 5). Arrows indicate missing cone photoreceptors. Brackets
indicate length of outer segments. Scale bars, 25 μm.
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Figure S 2.6 chd7 CRISPR mutant zebrafish continue to display photoreceptor defects at
14dpf

Figure S2.6. chd7 CRISPR mutant zebrafish continue to display photoreceptor defects
at 14 dpf. (A-C) Immunohistochemistry with a red-green cone antibody (Zpr1) in chd7+/+
(A,Aʹ), chd7+/- (B,Bʹ), and chd7-/- (C,Cʹ) retinal sections. Arrows indicate missing red-green
cone photoreceptors. (D-F) PNA labeling for cones in chd7+/+(D), chd7+/-(E), and chd7-/-(F)
retinal sections. (G-I) Immunohistochemistry with a rhodopsin antibody (1D1) in chd7+/+
(G), chd7+/- (H), and chd7-/- (I) retinal sections. (J) Quantification shows decrease in
red/green cones in chd7+/- and chd7-/- larvae compared to chd7+/+ (number of cones per
300 μm; ANOVA followed by t- test; n=10; ***p <.001. ONL, outer nuclear layer; INL,
Inner nuclear layer; GCL, ganglion cell layer; L, lens; D, dorsal; V, ventral. Scale bars 25
μm in A’-C’, D-I; 50 μm in A-C.
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Figure S 2.7 Other retinal cell types are unaffected in chd7 CRISPR mutant zebrafish.

Figure S2.7. Other retinal cell types are unaffected in chd7 CRISPR mutant zebrafish.
Immunohistochemistry on retinal sections from each genotype for amacrine and
ganglion cells with HuC/D antibody (A-C); bipolar cells with PKCa antibody (D-F);
horizontal cells (arrowheads) with Prox1 antibody (G-I); and Müller glia with glutamine
synthetase antibody (J-L). ONL, outer nuclear layer; INL, Inner nuclear layer; GCL,
ganglion cell layer; L, lens; ON, optic nerve; D, dorsal; V, ventral. Scale bar 50 μm.
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Figure S 2.8 Apoptosis is not increased in chd7 mutant retinas at 5 dpf

Figure S2.8. Apoptosis is not increased in chd7 mutant retinas at 5 dpf. (A–C) TUNEL
staining in chd7+/+, chd7+/-, and chd7-/- retinal sections. Arrows indicate TUNEL+ cells.
ONL, outer nuclear layer; INL, Inner nuclear layer; GCL, ganglion cell layer; L, lens; D,
dorsal; V, ventral. Scale bar 50 µm.
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Figure S 2.9 chd7 ENU maternal zygotic mutant zebrafish display more severe phenotypes
compared to zygotic mutants

Figure S2.9 chd7sa19732 maternal zygotic mutant zebrafish display more severe
phenotypes compared to zygotic mutants. (A-B) Immunohistochemistry with a redgreen cone antibody (Zpr1) in zygotic chd7-/- (A,Aʹ), maternal zygotic (MZ) chd7-/- retinas
at 5 dpf (B,Bʹ). (C-D) Immunohistochemistry with a rhodopsin antibody (4C12) in zygotic
chd7-/- (C,Cʹ), maternal zygotic (MZ) chd7-/- retinas at 5 dpf (D,Dʹ). (E) Maternal zygotic
mutants have a smaller retina perimeter compared to zygotic mutants. Measurements
taken from perimeter of retina normalized to nose to otolith length. (F) Quantification
showed decrease in red/green cones in maternal zygotic chd7-/- compared to zygotic
chd7-/- larvae (number of cones per 300 uM; n=10; ANOVA followed by t-test ***p
<.001). (G) Quantification showed no difference in rod photoreceptors between zygotic
chd7-/- and maternal zygotic (MZ) chd7-/- retinas (number of rods per 300 uM). ONL,
outer nuclear layer; INL, Inner nuclear layer; GCL, ganglion cell layer; L, lens; D, dorsal; V,
ventral. Scale bars 25 μm in A’-D’, and 50 μm in A-D.
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CHAPTER 3.

GENERATION OF A ZEBRAFISH KNOCK-IN LINE EXPRESSING MYC-TAGGED SOX11A USING
CRISPR/CAS9 GENOME EDITING
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3.1

Abstract
Advances in CRISPR-Cas9 genome editing technology have strengthened the role of

zebrafish as a model organism for genetics and developmental biology. These tools have
led to a significant increase in the production of loss-of-function mutant zebrafish lines.
However, the generation of precisely edited knock- in lines has remained a significant
challenge in the field due to the decreased efficiency of homology directed repair (HDR).
In this study, we overcame some of these challenges by combining available design tools
and synthetic, commercially available CRISPR reagents to generate a knock-in line carrying
an in-frame MYC epitope tag at the sox11a locus. Zebrafish Sox11a is a transcription factor
with critical roles in organogenesis, neurogenesis, craniofacial, and skeletal development;
however, only a few direct molecular targets of Sox11a have been identified. Here, we
evaluate the knock-in efficiency of various HDR donor configurations and demonstrate
the successful expression and localization of the resulting knock-in allele. Our results
provide an efficient, streamlined approach to knock-in experiments in zebrafish, which
will enable expansion of downstream experimental applications that have previously
been difficult to perform. Moreover, the MYC-Sox11a line we have generated will allow
further investigation into the function and direct targets of Sox11a.
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3.2

Introduction
The zebrafish (Danio rerio) is a powerful model organism for genetics and

developmental biology research [257]. Recently, the widespread adoption of CRISPRCas9 genome editing has enabled the generation of numerous zebrafish knockout lines
by exploiting error-prone DNA repair of Cas9 induced double strand breaks via nonhomologous end joining (NHEJ) [258]. This method has greatly facilitated zebrafish
reverse genetics approaches [259,260].
The CRISPR-Cas9 system can also be used to harness homology-dependent repair
(HDR) mechanisms. This approach involves providing a donor template that contains
homology to the CRISPR target site. Repair of the resulting double strand break is
accompanied by insertion of the donor sequence at the site of interest. This method
allows for the precise alteration of nucleotides in a coding region [261,262], or the
addition of sequences that encode fluorescent markers or epitope tags [263–265].
These additions can help overcome the lack of reliable antibodies in zebrafish and can
facilitate live imaging approaches.
While using the CRISPR system to produce knockouts is highly efficient, the
success rate of HDR remains very low in zebrafish [260]. Efforts to improve HDR
efficiency have included varying the type of donor sequence, the length and ratio of
homology arms, and the use of synthetic and chemically modified donors and gRNAs
[264–269]. These experiments have produced widely variable results, and there is little
consensus in the field as to what produces the highest efficiency of sequence
integration [270]. Additionally, germline transmission, expression, and function of the
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knock-in allele are not always demonstrated after successful donor sequence
integration.
In this work, we sought to establish a knock-in zebrafish line in which an in-frame
MYC epitope tag is incorporated into the coding region of the developmentally
important transcription factor sox11a. Loss of Sox11a expression in zebrafish has
previously been associated with numerous developmental defects; however, the
current lack of a reliable Sox11a antibody has limited further investigation into its
function and downstream transcriptional targets [234,271].
We determined the HDR insertion efficiency of various chemically modified
donor templates. An established founder was then evaluated for germline transmission,
functional integration, and off-target effects. The streamlined and efficient approach we
describe should be easily adoptable for other researchers. Moreover, our MYC-Sox11a
transgenic line provides a useful new reagent for further studies of its role in
development.

3.3

Materials and Methods

3.3.1 Zebrafish Lines and Maintenance

Zebrafish were bred, raised, and housed at 28.5°C on a 14-hour light:10-hour
dark cycle in compliance with established protocols for zebrafish husbandry [241]. All
animal procedures were carried out in accordance with guidelines established by the
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University of Kentucky Institutional Animal Care and Use Committee and the ARVO
Statement for the Use of Animals in Ophthalmic and Vision Research. Wildtype zebrafish
(AB strain) were obtained from the Zebrafish International Resource Center (ZIRC,
Eugene, OR).
3.3.2 CRISPR Design and Microinjections

The sox11a target site and donor template were designed using the Integrated
DNA Technologies Alt-R™ CRISPR HDR Design Tool
(https://www.idtdna.com/pages/tools/alt-r-crispr-hdr-design-tool; IDT, Coralville, IA).
The target site for genome editing was selected in the 5’UTR of sox11a, 16 base pairs
(bp) upstream of the start codon. The donor template sequences were designed with
the MYC tag sequence placed just after the start codon and included 40 bp of left arm
and 80 bp of right arm homology (Figure 3.1A). The donor templates were synthesized
and supplied by IDT as two Alt-R HDR Donor Blocks (Donor A and Donor B), an
unmodified double stranded template (Donor C), and two single stranded Alt-R HDR
Donor Blocks (forward strand Donor D and reverse strand Donor E).
The Alt-R CRISPR-Cas9 crRNA was synthesized by IDT and was duplexed with AltR CRISPR-Cas9 tracrRNA (IDT: 1073190) in a Eppendorf Mastercycler with the following
program: 95°C for 5 minutes, cooling to 25°C at a rate of 0.1°C/second, (Eppendorf,
Enfield, CT). Cas9 protein was purchased as Alt-R® S.p. Cas9 Nuclease V3 (IDT:
1081058). One-cell stage embryos were injected with 250 pg gRNA, 500 pg Cas9, 37.5
pg HDR template, and Dextran red.
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3.3.3 Insertion Screening
Genomic DNA (gDNA) was extracted from whole embryos or tails of injected
adult fish or their progeny. Tissue was placed in 50mM sodium hydroxide and incubated
at 95°C for digestion. The solution was neutralized with 1 M Tris-HCl, pH 8.0. The gDNA
was PCR amplified using primers described in Supplemental Table 1. Products were
visualized on a 10% polyacrylamide gel. Products that matched the expected insertion
size were extracted from the gel into dialysis tubing (Thermo Scientific: 88243, Rockford,
IL), ligated into pGEM-T Easy (Promega: A1360, Madison, WI), and sequenced with
universal T7 and Sp6 primers (Eurofins Genomics Services, Louisville, KY).
3.3.4 Immunohistochemistry and RNAscope
Embryos were fixed overnight in 4% paraformaldehyde, then incubated
overnight in 10% followed by 30% sucrose at 4°C. 10µm transverse cryosections were
taken on Leica CM1900 crysostat (Leica Biosystems, Buffalo Grove, IL).
Immunohistochemistry was performed on cryosections as previously described
with slight modifications for indirect antibody detection [247]. We used an anti-MYC
primary antibody (9B11, 1:1000; Cell Signaling #2276, Danvers, MA) followed by signal
amplification with goat anti-mouse IgG horseradish peroxidase (1: 500) (Perkin Elmer
Inc: NEF822001EA, Waltham, MA). The TSA plus Cy3 Kit (1:1500) (Perkin Elmer Inc:
NEL744001KT, Waltham, MA) was used for detection. The sections were counterstained
with 4′, 6-diamidino-2-phenylindole (DAPI, 1:10,000 dilution, Sigma-Aldrich). Images
were obtained on a Nikon Eclipse Ti-U inverted fluorescent microscope (Nikon
Instruments, Melville, NY)
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The sox11a RNAscope probe was obtained from Advanced Cell Diagnostics (ACD:
590461, Newark, CA) and labelling was carried out on cryosections according to
RNAscope™ Multiplex Fluorescent V2 Assay protocol.
At least 10 embryos were analyzed per timepoint, and 3 separate biological
replicates were performed for each experiment.
3.3.5 RT-PCR
Total RNA was extracted from whole sox11aMYC embryos at 48 hpf using TRIzol
reagent (Invitrogen, GrandIsland, NY). First strand cDNA was synthesized from 0.5 μg of
the extracted RNA using GoScript Reverse Transcriptase System (Promega, Madison,
WI). PCR primers were designed to amplify a unique region of the MYC tag and the
junction of sox11a-MYC (Eurofins Genomics, Supplemental Table 1). PCR products were
visualized on a 10% polyacrylamide gel.
3.3.6 Off-Target Screening
The top 50 potential off-target sites were compiled using CRISPOR
(http://crispor.tefor.net/) , Cas-OFFinder (http://www.rgenome.net/cas-offinder/) and
CRISPR-Cas9 guide RNA design checker (IDT,
https://www.idtdna.com/site/order/designtool/index/CRISPR_SEQUENCE) 272,273].
These targets were used to design an rhAMP Seq Amplicon Sequencing panel (IDT).
Genomic DNA was extracted from tails of sox11aMYC and wildtype fish with Monarch
Genomic DNA Purification Kit (NEB: T3010S, Ipswich, MA). Targeted amplicons and
rhAMP Seq library were produced according to the rhAmpSeq library kit manual. The
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prepared libraries were then sequenced on an Novaseq S4 Illumina platform (Novogene,
Sacramento, CA). Sequencing data were analyzed with rhAmpSeq™ CRISPR Analysis Tool
(IDT).
3.3.7 Data Analysis and Figure Construction
Schematics in Figures 1, 2, and 4 were created using BioRender (biorender.com).
All figures were constructed using Photoshop (Adobe version 22.0.0).
3.4

Results

3.4.1 Knock-in design and donor template production
To develop an efficient and direct method to knock-in an epitope tag (MYC) at
the 5’ end of the coding sequence of zebrafish sox11a, we utilized a synthetic crRNAtracrRNA and Cas9 ribronucleoprotein (RNP) complex developed by Integrated DNA
Technologies (IDT), which has previously been shown to produce a high rate of
mutagenesis in zebrafish [269,274]. We used IDT’s HDR Design Tool to choose the target
site and donor sequence for the knock-in experiment. We selected a crRNA
corresponding to a site 16 base pairs (bp) upstream of the sox11a transcription start site
(Supplementary Table 3.1), which had high on-target and low off-target scores. Our
HDR donor design included 40 bp left homology and 80 bp right homology arms, based
on previous work showing that homology arm asymmetry provides a slightly higher
efficiency for HDR [269]. This design resulted in a 169 bp donor template that includes
the MYC epitope sequence in-frame and just downstream of the sox11a start codon
(Figure 3.1A).
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Given that there is currently no consensus on which type of donor sequence
(single or double stranded) produces the highest efficiency for HDR we decided to test
five different donor templates. In collaboration with IDT, we obtained an unmodified
double-stranded template (Donor C), two double-stranded donors, each with distinct
chemical modifications (Donors A and B), a forward strand oriented single-stranded
chemically modified donor (Donor D), and a reverse strand oriented single-stranded
chemically modified (Donor E), (Figure 3.1B). The specific chemical modifications of
Donor A are now incorporated into a commercially available product and are referred to
as Alt-R HDR Donor Blocks.
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Figure 3.1 Knock-in design for MYC-sox11a

Figure 3.1 Knock-in design for MYC-sox11a. A. Schematic of sox11a locus, including
Cas9 target site (scissors) and MYC-donor template. B. Depiction of five different donors
(A-E). Donor A, Double Stranded Alt-R Modified #1; Donor B, Double Stranded Alt-R
Modified #2; Donor C, Double Stranded unmodified; Donor D, Forward single strand AltR Modified; Donor E, Reverse single strand Alt-R Modified.

3.4.2 Screening for knock-in efficiency by donor and germline transmission
Wildtype zebrafish embryos were microinjected with the sox11a targeting
crRNA-tracrRNA duplex and Cas9 protein complex along with one of the donors at the
one cell stage. Injected embryos were raised to adulthood and tail clipped for genomic
DNA extraction. We analyzed twenty fish for each donor by polymerase chain reaction
(PCR) with primers located on either side of expected insertion site (Supplementary
Table 3.1). Based on the length of the MYC epitope, successful HDR would result in a 30
bp insertion, producing an amplicon of 224 bp compared to the wildtype size of 194 bp
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(Figure 3.2A). We sequenced DNA purified from bands of the correct size, and analyzed
the sequences for evidence of HDR-mediated insertion of the MYC epitope. Insertions
were characterized as perfect or imperfect, depending on whether any additional indels
were detected at the target site. Donors A and E were the only two donors that showed
evidence of HDR. For each donor, the proportion of injected individuals that harbored
the donor sequences was 18% and 9%, respectively. However, only Donor A produced a
perfect integration resulting in the complete insertion of MYC at the correct site with no
other indels (Figure 3.2B, 3.2C).
The Donor A founder fish was then outcrossed to wildtype fish and the offspring
were analyzed for MYC insertion as described above. Seventeen out of 33 F1 progeny
carried the MYC epitope, a germline transmission rate of over 50% (Figure 3.2D). These
results indicate that an epitope knock-in can be generated with use of CRISPR-Cas9
complex in combination with an Alt-R double-stranded HDR donor block.
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Figure 3.2 Detection of HDR to generate MYC-sox11a

Figure 3.2 Detection of HDR to generate MYC-sox11a. A. Example of polyacrylamide gel
used to observe insertion events in injected zebrafish. Asterisks represent samples that
display an upper band of the correct size for MYC insertion; NT, no template. B.
Efficiency of homology directed repair (HDR) for the five different donors in adult
founder zebrafish and whether the HDR events included additional indels (Imperfect) or
were precise (Perfect). C. Chromatograms from Sanger sequencing of wildtype and
knock-in founders from Donor A. D. Percent of germline transmission of the knock-in
allele to F1 progeny.

3.4.3 Validation of MYC-Sox11a expression in knock-in line
To determine whether MYC-Sox11a mRNA and protein were detectable in our
knock-in line, we performed RT-PCR with three different primer sets on RNA extracted
from heterozygous MYC-sox11a embryos. Primer pair 1 was outside insertion site,
primer pair 2 has a forward primer anchored in MYC, and primer pair 3 has a forward
primer at the junction of MYC and sox11a. All three primer pairs produced the
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expected PCR product sizes, indicating that MYC is indeed present in the mRNA
transcribed from the sox11a locus of the knock-in animals (Figure 3.3A).
To confirm that MYC-tagged Sox11a is translated and detectable we completed a
series of immunohistochemistry (IHC) experiments. Retinal and brain sections were
obtained from embryos at 24, 48, and 72 hours post fertilization (hpf) and IHC was
performed with an anti-MYC epitope antibody (Figure 3.3C-F). Fluorescence detection
with a fluorescently labeled secondary antibody did not produce a detectable signal
(data not shown). Therefore, we performed IHC followed by indirect detection with
horseradish peroxidase catalyzed tyramide signal amplification (TSA; Figure 3.3C-E).
Consistent with previous work from our lab describing sox11a expression in the
developing retina [234], at 48 hpf anti-MYC positive cells were detected in the ganglion
cell layer (GCL), and at 72hpf MYC+ cells were detectable in the GCL, in some cells of the
inner nuclear layer (INL), and in the persistently neurogenic ciliary marginal zone (CMZ).
Control sections (no primary antibody, no TSA, and uninjected) had no signal (Figure
3.3G-J). Interestingly, MYC expression was also detected throughout the developing
retina at 24 hpf and in some INL cells at 48 hpf, which was not detected by in situ
hybridization in our previous study [234]. This could be due to the increased sensitivity
of TSA amplification or to differences in Sox11a protein versus sox11a mRNA stability.
Using the more sensitive technique of RNAscope, we found that the MYC-Sox11a
expression pattern was similar to sox11a mRNA expression in the retina at 48 hpf
(Figure 3.3F). In the brain, we detected MYC-Sox11a expression in the telencephalon,
posterior ventral diencephalon, and ventral midbrain at 24 hpf, all of which are
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consistent with published descriptions of sox11a expression in this region (Figure 3.3B)
[275]. Taken together, these results confirm that the MYC-tagged Sox11a protein is
detectable and is expressed in a similar manner to endogenous, untagged sox11a.
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Figure 3.3 Validation of MYC-sox11a expression

Figure 3.3 Validation of MYC-sox11a expression. A. RT-PCR of MYC-sox11a mRNA.
Location of primer sets P1, P2, and P3 are indicated in the schematic. S, sample; -RT, no
reverse transcriptase; NT, no template B. Immunohistochemistry of 24 hpf brain section
for MYC-Sox11a confirms expected expression pattern in the telencephalon (t),
posterior diencephalon, and ventral midbrain (vm). (C-F) Immunohistochemistry for
MYC-sox11a in the developing retina at 24 I (C), 48 hpf (D), and 72 hpf (E); MYC-Sox11a
expression is detected throughout the neural retina at 24 hpf, and in the ganglion cell
layer, the inner nuclear layer, and the ciliary marginal zone at 48 and 72 hpf. F.
Expression pattern of sox11a at 48 hpf detected by RNAscope for comparison. G-J.
Control sections at 48 hpf: G, no primary antibody; H, no horseradish peroxidase (HRP)
amplification; I, no Tyramide signal amplification (TSA); and J, wildtype uninjected
retina. L, lens; NR, neural retina; GCL, ganglion cell layer; INL, inner nuclear layer; ONL,
outer nuclear layer; CMZ, ciliary marginal zone; t, telencephalon; h, hypothalamus; vm,
ventral midbrain; c, cerebellum. Scale Bar, 100 uM.
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3.4.4 Sequencing screen for off-target and on-target integration
Double stranded DNA donors have been reported to integrate at off-target
locations in the genome [276,277], therefore we investigated whether there were any
off-target insertions or other editing events in our MYC-Sox11a knock-in line. We
utilized targeted amplicon sequencing of a DNA library containing 50 potential off-target
sites identified from three different off-target prediction programs (compiled by the IDT
rhAmp Seq CRISPR Analysis System); DNA libraries were then prepared from wildtype
zebrafish and the MYC-Sox11a knock-in line [272,273]. The libraries were sequenced,
and the sequencing data were analyzed in two different ways (Figure 3.4A).
First, using rhAmpSeq CRISPR Analysis Tool we analyzed our sequencing data for
all variants present by comparing the sequencing data to the zebrafish genome
assembly, GRCz11. There were 10 sites in our knock-line that displayed a significant
percentage of variants in the sequencing reads compared to the reference genome.
However, 8 of the 10 sites also contained the same variant in the wildtype DNA (Figure
3.4B), indicating that these are likely single nucleotide polymorphisms (SNPs) present in
our laboratory stocks of wildtype zebrafish and thus are not Cas9-mediated editing
events. For the two variants that were not present in wildtype sequence, the first is the
intended target site of sox11a. The second, 12:-15786693, is located in the intronic
region of the gene supervillind. While this may represent a true off-target editing event,
the number of sequence reads that mapped to this site was very low (only 397 total
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reads, compared to an average of 344,953 reads for the other sites); therefore, we
suspect this result is an artifact due to poor amplicon production.
Next, we used the rhAmpSeq CRISPR Analysis Tool to scan for all instances of
HDR integration using the sequence of the donor template as a guide. The only site
detected as an HDR event was the on-target site of sox11a (Figure 3.4C). This HDR event
was present in about 88% of the sequencing reads from the knock-in line and as
expected was not detected in the wildtype line. Taken together, these results confirm
that MYC was inserted at the target site but not at any potential off-target sites.
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Figure 3.4 rhAMP Sequencing analysis for confirmation of insertion and screening for offtarget events

Figure 3.4 rhAMP Sequencing analysis for confirmation of insertion and screening for
off-target events. A. Workflow schematic for design, production, and analysis of
amplicon sequencing. B. Table characterizing detected variants in knock-in MYC-sox11a
versus and wildtype genomic DNA. C. Chart depicting percent of HDR events in knock-in
MYC-sox11a and in wildtype fish.

3.5

Discussion
In this study, we describe a direct and simplified method for establishing a

zebrafish transgenic knock-in line that introduces a MYC epitope tag at the N-terminus
of Sox11a. We utilized readily available tools from Integrated DNA Technologies (IDT) to
design our reagents, including the synthetic crRNA for sox11a and the donor template
containing the MYC tag sequence. We tested different chemical modifications of the
donor template which we screened for efficiency of successful HDR. A chemically
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modified dsDNA donor, Alt-R HDR Donor Block, successfully introduced MYC in frame
after the start site of sox11a and this founder fish has produced a stable line by germline
transmission. This knock-in line was further validated for detection of MYC and
establishes a tool for downstream experiments which we previously did not have.
Similar to some previous studies, our approach relied on commercially
synthesized in-vitro donors [269,278]allowing for more time spent on injecting and
screening, resulting in an increased number of potential founders. The caveats to this
approach are that synthetic and commercial synthesis of the donor could lead to the
introduction of errors into the template and there may be limitations in the production
of complex sequences.
While we tested five different donors only two produced any evidence of HDR
and of these only one donor produced a perfect HDR event with no other mutations
resulting in an efficiency of 4.5%. However, we note that one of the three imperfect
HDR events for Donor A did have MYC inserted in the right position but contained an
indel in the untranslated region upstream of the start site. This founder fish may also
have been a suitable line after further functional studies, in which case the efficiency of
HDR could be as high as 9%. Nevertheless, even 4.5% falls within the range of previously
reported incorporation of epitope tags through HDR and is consistent with the rate of
previously reported synthetic dsDNA donors [269,279].
One striking finding of our approach is that it appears to have significantly
improved germline transmission (~52%) compared to previous attempts (10-30%)
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[280,281]. Indeed, another group reported successful knock-in of a composite HBH3xFLAG tag at the same position as our MYC tag in sox11a. Using a long single-stranded
DNA donor (lssDNA), this group reported a 12% correct integration of the 3X FLAG, but
only 13-25% germline transmission in F1 fish [270].In addition to the increased germline
transmission, we validated MYC-Sox11a mRNA and protein expression. MYC-Sox11a
expression was not detected by conventional IHC, perhaps because of the low
endogenous expression of Sox11a, or the insertion of only a single copy of the MYC
epitope; in the future a 3xMYC could potentially address this problem. Nevertheless,
ours is the first demonstration of successful protein expression of an epitope-tagged
sox11a, and allows for this knock-in line to be used for downstream functional and
target site detection experiments.
Efficient methods for functional integration of an epitope tag in a gene of
interest are critical for the field because they permit researchers to circumvent the
absence of reliable antibodies for zebrafish proteins [282]. With the successful
integration of MYC into sox11a we can continue our research investigating its role in the
development of the retina. Specifically, the knock-in line will allow us to determine the
precise retinal cell types expressing Sox11a, and will facilitate experiments like
CUT&RUN to further our understanding of the Sox11a target genes in the retina.
Furthermore, this approach should be applicable to any gene that can be targeted by
CRISPR/Cas9, which will improve the value of zebrafish as genetic and developmental
model organism.
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3.6

Supplemental Tables

Table S3.1 PCR primers used in this study
Primers

Sequence

Use

sox11a F

GTGGGTGAACCTCTGAGTCG

Screening/RT-PCR (P1)

sox11a R

ATCGGTCGCTTTATGTGTCC

Screening/RT-PCR (P1)

MYC F

AGAAGCTGATCTCCGAAGAGGA

RT-PCR (P2)

sox11a-MYC F

ACCATGGAGCAGAAGCTGAT

RT-PCR (P3)

sox11a R

CTTTTCGCTGTCTTTCAGCA

RT-PCR (P2 and P3)

crRNA

TATTTTGGACTGACAACGCACGGCAA
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Abstract
The molecular mechanisms underlying the ocular birth defects observed in

individuals with CHARGE are poorly understood. Previous work from our lab has shown
that knockdown of zebrafish Sox11, a member of the SoxC family of transcription
factors, results in microphthalmia, coloboma, brain, trunk, and heart defects, all of
which are phenotypes observed in CHARGE syndrome. Furthermore, a duplication of
Sox11 has been identified in a individual clinically diagnosed with CHARGE syndrome,
and CHD7 has been shown to directly interact with Sox11 and Sox4 in neural stem cells.
Taken together, these data strongly suggest that loss of SoxC expression contributes to
the ocular and other phenotypes observed in Chd7-associated CHARGE syndrome. In
this chapter, I begin to further investigate the role that Sox11 plays in the phenotypes
seen in CHARGE syndrome by generating Sox11-mutant zebrafish using the CRISPR-Cas
system. The resulting Sox11 mutant lines are preliminarily characterized for phenotypes
related to CHARGE. These experiments will provide a better understanding of the
potential role of Sox11 in the pathogenesis of CHARGE syndrome.
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4.2

Introduction
CHARGE syndrome is a genetic neural cristopathy characterized by coloboma,

heart defects, choanal atresia, growth retardation, genital abnormalities, and ear
abnormalities [130,135].
Pathogenic variants in Chromodomain helicase DNA binding protein 7 (CHD7),
are the most common cause of CHARGE syndrome [131,150], however the mechanistic
details of how these CHD7 variants contribute to ocular defects associated with CHARGE
syndrome remain unknown. As CHD7 is a chromatin remodeling transcription factor,
identification and characterization of downstream targets of CHD7 may provide insight
into the pathogenesis of CHARGE syndrome.
Two identified target genes of CHD7 in adult neural stem cells are Sox4 and
Sox11 [208]. These genes are members of the group C family of Sox transcriptional
activators, whose name is derived from a shared DNA binding domain (the SRY-box)
originally identified in the mammalian sex-determining gene SRY. SoxC factors have
been implicated in a wide spectrum of developmental processes. Sox11 specifically has
been shown to play a role in organogenesis and neurogenesis, as well as craniofacial and
skeletal development. In addition, abnormal expression of Sox11 has been associated
with a wide spectrum of cancers [283]. Furthermore, Sox11 has been implicated in
several human developmental disorders. First, chromosomal rearrangements near the
Sox11 locus and pathogenic variants in Sox11 are associated with ocular malformations,
including anterior segment dysgenesis and MAC (microphthalmia, anophthalmia, and
coloboma) [234,284]. Second, Sox11 pathogenic variants have been linked to
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neurodevelopmental disorders such as Coffin-Siris syndrome, which is characterized by
developmental delay, feeding difficulties, facial dysmorphology, microcephaly and
hypoplastic nails of the fifth digits [285]. Finally, an individual with CHARGE syndrome
has been diagnosed with duplication in Sox11 and not a pathogenic variant in CHD7
[235]. Taken together, the role of Sox11 in developmental processes and its connection
to human disorders makes it a prime candidate for further study in CHARGE syndrome
pathogenesis.
Sox11 function has been studied in various animal models, including the mouse,
frog, and zebrafish. In the mouse, germline knockout of Sox11 leads to perinatal
lethality due to cardiac malformations; mutant embryos also display ocular
abnormalities including eyelid closure defects, anterior segment dysgenesis,
microphthalmia, a persistent lens stalk, delayed lens formation, and coloboma
[286,287]. Knockdown of Sox11 in frog results in microphthalmia in addition to retinal
lamination defects [288]. Finally, our lab has previously shown that morpholinomediated knockdown of the two co-orthologs of Sox11, sox11a and sox11b, in zebrafish
causes various developmental defects, including microphthalmia, coloboma, and brain,
trunk, and heart abnormalities in addition to the loss of rod photoreceptors [234].
While these models have begun to connect Sox11 with defects seen in CHARGE
syndrome, further characterization needs to be completed to further elucidate its role.
The use of morpholinos to knockdown genes in zebrafish has provided a well-accepted
avenue for genetic manipulation, however the advent of CRIPSR-Cas9 technology allows
for the development of germline genetic mutants, permitting more in-depth loss-of105

function studies. To that end, in this chapter I describe the process of designing and
developing sox11a and sox11b CRISPR mutants and the initial characterization of their
gross morphology and retinal development.
4.3

Materials and Methods

4.3.1 Zebrafish Line and Maintenance
Zebrafish were bred, raised, and housed at 28.5°C on a 14-hour light:10-hour
dark cycle in compliance with established protocols for zebrafish husbandry [241]. All
animal procedures were carried out in accordance with guidelines established by the
University of Kentucky Institutional Animal Care and Use Committee and the ARVO
Statement for the Use of Animals in Ophthalmic and Vision Research. Wildtype zebrafish
(AB strain) were obtained from the Zebrafish International Resource Center (ZIRC,
Eugene, OR).
4.3.2 CRISPR Design and Microinjections
The first set of sox11a and sox11b target sites and single strand DNA
oligonucleotides used to generate the guide RNAs were selected using the CRISPOR
online tool (http://crispor.tefor.net/) [273]. Initial target sites for CRISPR/Cas9 genome
editing were selected upstream of the high mobility group (HMG) DNA-binding domain
and just upstream of the transactivation domain of sox11a and sox11b (sequences listed
in Table S4.1).
Oligos were annealed at a concentration of 100 μM (5 minutes at 95-100°C, then
slowly cooled to room temperature and ligated into the pDR274 vector (Addgene:
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42250) digested with BsaI (NEB: R0535S). Recombinant vectors containing the gRNA
insert sequence were digested with DraI (NEB: R0129S) and the insert was amplified by
PCR. The PCR product was purified (QIAquick PCR purification kit), in vitro transcribed
using Ambion-MEGAscript T7 Transcription Kit (Life Technologies#AM1334), then
purified by phenol:chloroform extraction followed by ethanol precipitation. gRNAs were
stored at -80°C until ready for injection. Cas9 protein was obtained from NEB (EnGen
Spy Cas9 NLS; M0646T). One-cell stage embryos were injected with both gRNAs (100
ng/embryo), 300 ng/embryo of Cas9, and Dextran red.
The second set of guide RNAs for sox11b were designed using the Integrated
DNA Technologies Custom Alt-R® CRISPR-Cas9 guide RNA design tool
(https://www.idtdna.com/site/order/designtool/index/CRISPR_CUSTOM IDT, Coralville,
IA). The target sites were selected in the HMG domain and downstream of the HMG
domain (sequences listed in Table S4.1). The Alt-R CRISPR-Cas9 crRNA was synthesized
by IDT and was duplexed with Alt-R CRISPR-Cas9 tracrRNA (IDT: 1073190) in a Eppendorf
Mastercycler with the following program: 95°C for 5 minutes, cooling to 25°C at a rate of
0.1°C/second, (Eppendorf, Enfield, CT). Cas9 protein was purchased as Alt-R® S.p. Cas9
Nuclease V3 (IDT: 1081058). One-cell stage embryos were injected with 50-100 pg
gRNA, 250pg Cas9, and Dextran red.
4.3.3 Deletion Screening
Genomic DNA (gDNA) was extracted from whole embryos or tails of injected
adult fish or their progeny. Tissue was placed in 50mM sodium hydroxide and incubated
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at 95°C for digestion. The solution was neutralized with 1 M Tris-HCl, pH 8.0. The gDNA
was PCR amplified using primers described in Supplemental Table 4.1. PCR products
were run on a 2% gel. Products that appeared to contain the expected deletion were
extracted from the gel into dialysis tubing (Thermo Scientific: 88243, Rockford, IL),
ligated into pGEM-T Easy (Promega: A1360, Madison, WI), and sequenced with universal
T7 and Sp6 primers (Eurofins Genomics Services, Louisville, KY). Sox11a genotyping was
also completed using automated genotyping services through Transnetyx (Cordova, TN).
4.3.4 RNA Isolation and real-time quantitative RT-PCR (qPCR)
Total RNA was extracted from whole embryos at 48 hpf using TRIzol reagent
(Invitrogen, GrandIsland, NY). First strand cDNA was synthesized from 0.5 μg of the
extracted RNA using GoScript Reverse Transcriptase System (Promega, Madison, WI).
PCR primers were designed to amplify unique regions of the SoxC transcription factors
(sox4 and sox11), atp5h, and elf1a cDNAs (Primer sequences in Supplemental Table 1).
Faststart Essential DNA Green Master mix (Roche) was used to perform qPCR on a
Lightcycler 96 Real-Time PCR System (Roche). The relative transcript abundance was
normalized to atp5h expression as the housekeeping gene control and was calculated as
fold-change relative to wild type siblings. qPCR experiments were performed with three
biological replicates and two technical replicates.
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4.3.5 Immunohistochemistry and RNAscope
Embryos were fixed overnight in 4% paraformaldehyde, then incubated
overnight in 10% followed by 30% sucrose at 4°C. 10µm transverse cryosections were
taken on a Leica CM1900 crysostat (Leica Biosystems, Buffalo Grove, IL).
Immunohistochemistry was performed on cryosections as previously described
[247]. Antibodies used were 4C12 (mouse, 1:100) generously provided by J. Fadool
(Florida State University, Tallahassee, FL), which labels rod photoreceptors; Zpr-1
(mouse, 1:20, ZIRC), which labels red-green double cones. Alexa fluor conjugated
secondary antibodies (Invitrogen, Grand Island, NY) were used at 1:250 dilution. The
sections were counterstained with 4′, 6-diamidino-2-phenylindole (DAPI, 1:10,000
dilution, Sigma-Aldrich). Images were obtained on a Nikon Eclipse Ti-U inverted
fluorescent microscope (Nikon Instruments, Melville, NY)
The sox11a, sox11b, and chd7 RNAscope probes were obtained from Advanced
Cell Diagnostics (ACD: 590461, Newark, CA) and labelling was carried out on
cryosections according to RNAscope™ Multiplex Fluorescent V2 Assay protocol. Images
were obtained on a Leica SP8 DLS confocal microscope.
At least 10 embryos were analyzed per timepoint, and 3 separate biological
replicates were performed for each experiment.
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4.3.6 Cells Counts and Eye Size
The circumference of the eye was measured and normalized to body size based
on length from nose to otolith. The diameter of the lens was measured and normalized
to the curvilinear length of the retina.
For comparing and counting photoreceptors, only retinal cryosections containing
the optic nerve were used for cell counts. Counts were taken from three 100 μm regions
of the outer retina: 50 μm from dorsal margin, 50 μm dorsal to the optic nerve, and 50
μm from ventral margin. Sections were analyzed from a minimum of 10 wild type and
10 mutant embryos.

4.3.7 Statistical Analysis
Statistical analysis was performed using one-way ANOVA followed by two-factor,
unpaired t-test, using GraphPad software. P<0.05 was considered significant and is
indicated as *P<0.05, **P<0.01 and ***P<0.001. Boxplots were generated using R
(version 3.6.2)/R studio (version 1.2.5033) ggplot2package. All figures were constructed
using Photoshop (Adobe version 22.0.0).
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4.4

Results

4.4.1 Initial CRISPR Design and Screening
To generate knockouts of zebrafish sox11a and sox11b I wished to create large
genomic deletions and therefore designed two CRISPR target sites for each gene. These
two sites were upstream of the high mobility group (HMG) domain and upstream of the
transactivation domain for both sox11a and sox11b (Figure 4.1A). The two gRNAs for
each gene were synthesized and injected along with Cas9 protein into single cell
embryos (independent injections for each gene). Injected embryos were grown to adults
and then screened by polymerase chain reaction (PCR) after tail clipping and genomic
DNA extraction. PCR primers were designed outside of the two target sites and products
were analyzed on an agarose gel. Successful CRISPR editing events would result in
laddering of products on the gel due to the mosaic nature of genome editing (Figure
4.1B). Thousands of embryos were injected for both sox11a and sox11b and hundreds of
the surviving embryos were screened for mutations. For both sox11a and sox11b, this
resulted in three founder fish for each gene (Figure 4.1C). The mutations in these
founder fish were characterized by gel extraction and DNA sequencing. Founders
contained an array of large deletions and insertions (Figure 4.2A), indicating that
CRISPR-mediated genome targeting had been successful. However, when these six
different founders were outcrossed to wild type fish to generate F1 offspring no
successful germline transmission of the mutant allele was identified in over 100
embryos screened from each founder (Figure 4.2B). This was an indication that while
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there was successful CRISPR editing, germline cells were not being successfully targeted
and therefore no stable knockout line was produced from this round of injections.
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Figure 4.1 CRISPR Target Site Design and Screening

Figure 4.1 CRISPR Target Site Design and Screening A) Zebrafish have two co-orthologs
of SOX11, sox11a and sox11b. CRISPR target sites (red) were chosen to delete the region
including the high mobility group (HMG) DNA-binding domain (green) up to the
transactivation domain (blue) of sox11a and sox11b. B) Primers (orange) were designed
around the CRISPR target sites and PCR was performed on DNA collected from F0
uninjected and injected embryos. The image shows gel electrophoresis of PCR products
from wild type (WT) and identified mutated (MUT) embryos; the wild type product size
is 1042 base pairs; 2-log ladder is shown for reference. C) Table depicting number of
injected, screened, and identified founders for sox11a and sox11b.
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Figure 4.2 CRISPR Founders and Germline Transmission

Figure 4.2 CRISPR Founders and Germline Transmission A) Mosaic mutations resulting
from CRISPR Injections. CRISPR target sites (red), high mobility group (HMG) DNAbinding domain (green) and the transactivation domain (blue), insertions (yellow). B)
Table depicting germline transmission for F1 heterozygotes from six founders for sox11a
and sox11b.

4.4.2 Secondary CRISPR Design and Screening
Since initial gRNA design and injections did not result in germline transmission, I
decided to perform additional injections with higher amounts of gRNA and Cas9 per
embryo for sox11a. In addition, I designed new CRISPR sites for sox11b using the Alt-R
CRISPR system through IDT (Figure 4.3A), which has been shown to have higher
targeting efficiency than our initial strategy and includes a tracrRNA to increase
nuclease resistance. I designed two target sites, one inside the HMG domain and the
other downstream of the HMG domain. Using higher concentrations of gRNA for
sox11a, and the Alt-R CRISPR strategy for sox11b, resulted in founders for both genes.
For sox11a this was a founder with a large deletion of 936 base pairs leading to a
premature stop codon and for sox11b the founder had a deletion of 356 base pairs and
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an insertion of 63 base pairs resulting in a frameshift and early stop codon (Figure 4.3B).
Both founders led to germline transmission and resulted in F1 heterozygotes when
outcrossed to wild type. These resulting mutations are predicted to result in severely
truncated proteins for both Sox11a and Sox11b (Figure 4.3C).

Figure 4.3 Secondary CRISPR design with resulting founders and predicted proteins

Figure 4.3 Secondary CRISPR design with resulting founders and predicted proteins (A)
CRISPR target sites (red) were chosen to disrupt the high mobility group (HMG) DNAbinding domain (green) and the transactivation domain (blue) of sox11a and sox11b,
sox11b was designed using Alt-R CRISPR System from IDT. (B) Founder mutations for
sox11a and sox11b indicating deletion size and insertions (yellow), and residual
homology to CRISPR sites (red), high mobility group (HMG) DNA-binding domain (green)
and the transactivation domain (blue). (C) Wild type and predicted truncated proteins
for Sox11a and Sox11b including partial homology for high mobility group (HMG) DNAbinding domain (green) and loss of the transactivation domain (blue).

4.4.3 Generation of stable sox11a and sox11b knockout lines
After identifying F1 heterozygotes for both sox11a and sox11b, I continued to
generate stable mutant lines by outcrossing these heterozygotes with wild type fish to
generate heterozygous F2s. The F2 generation was then in-crossed to generate an F3
generation that contained wild type, heterozygotes, and homozygous mutants (Figure
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4.4A). From these crosses, I was able to raise both male and female homozygous zygotic
mutants and I observed no decrease in survival or obvious mutant phenotypes. Given
that sox11a and sox11b mRNA are maternally deposited into the oocyte, I predicted
that I would not observe a phenotype in these zygotic mutants. Therefore, it was
essential to have both female and male adult homozygotes to generate maternal zygotic
mutants and prevent maternal deposition of wildtype sox11 mRNA [275]. Maternal
zygotic mutant progeny from homozygous mutant in-crosses were successfully
generated in a normal clutch size. I used qPCR to investigate sox11a and sox11b
expression in maternal zygotic sox11a-/- and sox11b-/- zebrafish embryos. In both mutant
lines, I observed significant reduction in the respective mRNA levels of the mutant
transcripts, suggesting that the mutations resulted in nonsense-mediated decay of the
mutant transcript (Figure 4.5A and B). I also investigated expression levels of other SoxC
transcripts in each mutant line. In the sox11b-/- line I observed a significant increase in
sox4a mRNA levels, whereas in the sox11a-/- line there was a slight increase in sox11b
mRNA levels. These increases could be a result of genetic compensation triggered by
non-sense mediated decay of the mutant mRNA which has been shown to lead to an
increase in transcription of genes with similar sequences [253]. Surprisingly, I also
observed significant reduction in sox4b mRNA levels in the sox11a-/- line, suggesting that
Sox11a may positively regulate sox4b expression.

116

Figure 4.4 Schematic for generating stable CRISPR Mutant Line

Figure 4.4 Schematic for generating stable CRISPR Mutant Line A) Schematic for
generation of Sox11 zebrafish mutants. Adapted from Wen Wen Dissertation, “The Role
of Sox4 in Regulating Choroid Fissure Closure and The Role of Sox4 in Regulating Choroid
Fissure Closure and Retinal Neurogenesis Retinal Neurogenesis”, 2016.

117

Figure 4.5 SoxC Transcription Factor Expression in Sox11 Mutant Lines

Figure 4.5 SoxC Transcription Factor Expression in Sox11 Mutant Lines A-B) qPCR
analysis of SoxC transcription factors (sox11a/b and sox4a/b) mRNA expression in
wildtype and maternal zygotic mutants at 48 hpf. * Denotes significance p<.05.

4.4.4 Gross morphological defects in sox11a and sox11b maternal zygotic mutants
To investigate how the loss of Sox11a and Sox11b affects gross morphological
development I used light microscopy to observe larvae from homozygous mutant incrosses. At 5 days post fertilization (dpf), maternal zygotic mutant larvae for both
sox11a and sox11b displayed lack of swim bladder, craniofacial defects, and heart
edema (Figure 4.6A). While all mutant larvae displayed a lack of developed swim
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bladder at 5 dpf, a subset of those larvae developed swim bladders by 7 dpf suggesting
that the mutations result in partially penetrant developmental delay. However, some
progeny continued to show defects such as curved body and craniofacial abnormalities
(Figure 4.6B). Interestingly, no obvious ocular defects such as microphthalmia or
coloboma were observed in sox11a or sox11b MZ mutants.
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Figure 4.6 Gross Morphological Defects in Sox11 Mutants

Figure 4.6 Gross Morphological Defects in Sox11 Mutants A) Morphological defects in
sox11a and sox11b maternal zygotic mutants at 5dpf compared to wild type (WT). Red
asterisk indicates lack of swim bladder; red arrow, craniofacial defects, green arrow,
heart edema. B) Gross morphology at 7dpf compared to wild type (WT). Red asterisk
indicates lack of swim bladder; red arrow, craniofacial defects.

4.4.5 Ocular phenotypes in sox11a and sox11b maternal zygotic mutants
Further characterization of Sox11 mutants was completed by performing
immunohistochemistry on retinal sections. This work confirmed that there was no
difference in eye size between wild type and sox11a and sox11b maternal zygotic
mutants (Figure 4.7G). However, there was a significant reduction in lens size in sox11b
mutants compared to wild type (Figure 4.7H). In addition, after quantifying the number
of photoreceptors through immunohistochemistry with rod and cone-specific
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antibodies, there was no difference in the number of red/green cones (Figure 4.7A-C, I),
but there was a reduction in the number of rod photoreceptors in both sox11a and
sox11b MZ mutants (Figure 4.7D-F, J). These defects in lens and rod photoreceptors are
consistent with our lab’s previous result characterizing sox11 morphants [234].
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Figure 4.7 Ocular Phenotypes in sox11a and sox11b maternal zygotic (MZ) mutants

Figure 4.7 Ocular Phenotypes in sox11a and sox11b maternal zygotic (MZ) mutants. AC) Representative images of transverse retinal sections of 5 dpf wild type, sox11a, sox11b
maternal zygotic mutants with Zpr1 antibody staining for red/green double cones. D-F, DF’) Representative images with 4C12 antibody staining for rod photoreceptors. G) Eye size
is comparable between wild type, sox11a, sox11b maternal zygotic mutants. H) Lens size
relative to eye size is reduced in sox11b mutants (t-test; n=10; *p< 0.05) I) Number of
red/green cone photoreceptors is comparable between wild type, sox11a, sox11b
maternal zygotic mutants J) Number of rod photoreceptors is decreased in sox11a and
sox11b maternal zygotic mutants. (t-test; n=10; *p< 0.05). D, dorsal; V, ventral; L, lens;
dpf, days post fertilization; GCL, ganglion cell layer; INL, inner nuclear layer; ONL, outer
nuclear layer; ON, optic nerve; WT, wild type. Scale bar 50µM in A-F and 25µM in D’-F’.
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4.4.6 Connection between Chd7 and Sox11 in ocular development
While Sox11 has been shown to be a target of Chd7 in neural stem cells and in
adult brain neurogenesis, a connection between these three genes in ocular
development and retinal neurogenesis has not been investigated. To explore this
possible connection, I determined whether the expression of chd7 co-localizes with
sox11a and/or sox11b during retinal development. To do this, I completed RNAscope
hybridization with sox11a, sox11b, and chd7 probes. At both 24 and 48 hours post
fertilization (hpf) there was clear colocalization of chd7 with both sox11a and sox11b
expression (Figure 4.8F-G,M-N). This could suggest a potential role for regulation of
Sox11 by Chd7 in retinal and ocular development that should be further investigated.

Figure 4.8 RNAscope expression of chd7, sox11a, sox11b in early retinal development

Figure 4.8 RNAscope expression of chd7, sox11a, sox11b in early retinal development.
A-G) Expression patterns at 24 hours post fertilization with individual probes (C-E) and
colocalizations (F-G). H-N) Expression patterns at 48 hours post fertilization with
individual probes (J-L) and colocalization (M-N). Areas of colocalization throughout
developing retina with increased concentration in ganglion cell layer (GCL). D, dorsal; V,
ventral; L, lens; hpf, hours post fertilization. Scale bar 50µM.
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4.5

Discussion
In this chapter, I describe the generation of stable mutant lines for the two

zebrafish co-orthologs of the Sox11 transcription factor, sox11a and sox11b. CRISPR
target sites were designed to generate large deletions and therefore disrupt the two
functional domains, the high mobility group (HMG) and the transactivation domain.
While several original founders were generated for each gene the efficiency of germline
transmission was zero for the first set of injections. By altering the concentration of
injected guide RNA (gRNA) and implementing a more efficient Alt-R CRISPR method new
founders were generated, and successful germline transmission was established. The
Alt-R method specifically had efficiency of editing and germline transmission of over
80% suggesting this approach should be used for all future CRISPR knockout
experiments, to save both time and resources.
The founder fish for each of the co-orthologs did in fact have large deletions
resulting in frame-shifts and premature termination codons, which should disrupt the
HMG and TAD domains and lead to severely truncated proteins. Heterozygotes from
these founders were further outcrossed and in-crossed to establish zygotic and
maternal zygotic mutants. The maternal zygotic mutants were investigated for mRNA
expression of sox4a/b and sox11a/b and displayed evidence of nonsense mediated
decay of the mutant transcript, and perhaps regulation and compensation of related
SoxC transcripts. Compensation for the loss of sox11 by sox4 has previously been shown
in our morpholino model where sox4a expression was elevated in sox11 morphants
[234]. In sox4 morphants overexpression of sox11 rescued the coloboma phenotype,
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suggesting the ability of SoxC family members to compensate between each other [233].
Furthermore, Sox4 has been shown to regulate a post-translational modification
(SUMOylation - small ubiquitin-related modifier) of Sox11 which alters the nuclear
localization of Sox11 and is thus a potential mechanism for compensation [289].
These results suggest that to fully observe the phenotype and role of SoxC
transcription factors in development it may be required to generate double mutants
(sox11a-/-sox11b-/-) and even quadruple mutants (sox4a-/-sox4b-/-sox11a-/-sox11b-/-) to
remove any compensation that may be occurring. To that end, crosses to generate
double sox11a-/-sox11b-/- mutants have been performed and offspring are currently
being genotyped; double sox4a-/-sox4b-/- mutants are already established in our lab,
which will allow for sox11a-/-sox11b-/- x sox4a-/-sox4b-/- double mutant crosses to occur
in the near future. These mutants will then be characterized for developmental and
ocular defects. Given our previous studies and work completed in mouse I expect these
quadruple mutants to have more severe phenotypes than sox4 and sox11 mutants
alone. Our lab’s morpholino work showed that sox4 and sox11 had redundant but also
distinct functions in ocular development. Both morphants displayed loss of rod
photoreceptors and coloboma that were rescued with overexpression of the other gene.
However, coloboma occurred at different penetrance and lens malformations were only
present in sox11 morphants [233,234]. Furthermore, SoxC members, and specifically
Sox4 and Sox11, have shown to be redundant in the development, differentiation, and
survival of neurons [290,291] . This includes cells of the spinal cord and retina where
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combined deletion of Sox4 and Sox11 in mouse led to a more severe phenotype than
single deletion [292,293].
Established maternal zygotic mutants for sox11a and sox11b were initially
characterized for gross morphological defects and showed delayed swim bladder
development, heart edema, and craniofacial defects. These defects should be further
characterized quantitatively to determine the penetrance of these phenotypes, in
addition to further defining the precise nature and onset of the craniofacial defects
through Alcian blue staining and other cartilage/bone assays. Furthermore, survival
curves should be established for these mutant lines to assess severity of these defects.
Other gross defects have been reported in previously described Sox11a CRISPR mutants
including microcephaly and skeletal abnormalities resembling phenotypes found in
Coffin-Siris Syndrome and should be further investigated in our mutants [271].
Preliminary ocular phenotypes were assessed in the maternal zygotic mutants
where sox11b mutants were shown to have a significantly smaller lens compared to
wildtype and both sox11a and sox11b mutants displayed a reduced amount of rod
photoreceptors. These results are consistent with previously reported phenotypes in
sox11 morphants and Sox11 null mice and suggest both distinct and redundant roles for
Sox11 in ocular development [234,294]. First, lens defects have been described only
with the loss of Sox11 and not Sox4 and thus is a distinct role of Sox11 in ocular
morphogenesis. While no direct targets of Sox11 have been identified in lens
development evidence has shown that zebrafish Sox11 negatively regulates Hedgehog
signaling (shha) in part due to controlling Bmp7b expression [234]. Bmp7 is expressed in
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the developing lens ectoderm and has been implicated in lens placode development
[295,296]. Furthermore, the bmp7b promoter in zebrafish contains two SoxC consensus
binding sites located approximately 950 bp upstream of the transcription start site,
suggesting that Sox11 may directly regulate expression of bmp7b [297]. This relationship
could be confirmed by completing CUT&RUN sequencing experiments with the epitope
tagged Sox11 knock-in lines that I am currently developing [298]. While lens
development seems to be a distinct role of Sox11, rod photoreceptor development
appears to be redundant with Sox4. Both sox4 and sox11 morphants display a loss of rod
photoreceptors and elevation of sox4 and sox11 expression were detected in a zebrafish
model of chronic rod photoreceptor degeneration and regeneration [233,234,299].
Previous work in the morphants indicate that loss of sox4 and sox11 does not influence
rod lineage precursors suggesting that these SoxC factors are important for terminal
differentiation and not specification of rods. This should be repeated and confirmed in
our CRISPR mutants along with work to determine potential targets of Sox11 in this
terminal differentiation.
Although some cases of coloboma in CHARGE syndrome have reported
involvement of the lens, there have been no other descriptions of lens and
photoreceptor defects in individuals with CHARGE [136,173,178]. This could suggest
potential separate roles for SoxC factors in ocular development that are not connected
to Chd7 or that these phenotypes have not yet been described. Further characterization
of Chd7 and Sox11 animal models in addition to work to identify direct targets of Chd7
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and Sox11 in ocular development can help to elucidate any connection between SoxC
and the ocular phenotypes of CHARGE.
The maternal zygotic lines described in this chapter as well as future double and
quadruple lines should be further characterized for other retinal cell defects. Mouse
conditional knockout of Sox4, Sox11, and Sox4/Sox11 in the optic vesicle led to a slight
reduction in retinal ganglion cells in single knockouts and a complete loss of retinal
ganglion cells and significant reduction in other retinal neurons in the double knockout
[292]. This suggests that deficits in retinal ganglion cells and other neurons could be
observed as SoxC contributions are depleted. Retinas should also be observed for cell
death given that the loss of Sox11 and Sox4 in the frog retina leads to an increase in
apoptosis [288]. In addition, the generation of these stable knockout lines allows for
extended examination beyond embryonic and larval development that was not possible
in the morphants. This includes investigating a potential role for SoxC factors in
continual rod neurogenesis as detected in the chronic rod photoreceptor degeneration
and regeneration zebrafish model [299]. Furthermore, in-vivo live imaging with these
mutants and fluorescent transgenic reporter lines can provide unique details on the
developmental dynamics that are altered with the loss of SoxC factors. This imaging
could include investigating the development of rods (XOPs:GFP), cones(TαC:EGFP), and
BMP signaling (BRE:GFP) [242,243,300].
Finally, preliminary results demonstrated that both co-orthologues of Sox11 had
overlapping expression with Chd7 in retinal development. This connection should be
further investigated, in addition to other tissues effected in CHARGE syndrome,
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especially considering the craniofacial defects observed in the sox11 MZ mutants. Taken
together, the Chd7 mutant lines described in Chapter 1 and the established Sox11
mutants described in this chapter, used in conjunction with transgenic reporter fish for
retinal cell types and neural crest cells will provide an avenue to further investigate the
connection between Chd7, Sox11, and the pathogenesis of CHARGE.
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4.6

Supplemental Table

Table S4.1 Primer Sequences
Primers

Sequence

Use

sox11a C1 F

TAGGCTCTGATGAAAGCGAATTCA

gRNA

sox11a C1 R

AAACTGAATTCGCTTTCATCAGAG

gRNA

sox11a C2 F

TAGGTCCGCGCAAAGCTCGGAGCT

gRNA

sox11a C2 R

AAACAGCTCCGAGCTTTGCGCGGA

gRNA

sox11b C1 F

TAGGCGGTGCCACCGAAACCGGAC

gRNA

sox11b C1 R

AAACGTCCGGTTTCGGTGGCACCG

gRNA

sox11b C2 F

TAGGCTCTCACACCGCGGACTTG

gRNA

sox11b C2 R

AAACCAAGTCCGCGGTGTGAGAG

gRNA

sox11b AltR C1

TCTCCAAAAGGCTGGGGAAG

crRNA

sox11b AltR C2

AGTCTATCAAAAGGGAACTT

crRNA

Sox11a Screening F

TGGAAAGAGTGGGTGAACCT

PCR

Sox11a Screening R

ACCTCTCTCCCGTGTGTGTT

PCR

Sox11b Screening F

TGTGTTTGAACATGGTGCAG

PCR

Sox11b Screening R

CAATAGTCCGGGAACTCGAA

PCR

Sox4a qPCR F

TCTTAGCGCTTTCAACGCG

qPCR

Sox4a qPCR R

TGCTCCACCATAGCCAGGT

qPCR

Sox4b qPCR F

ACGCCATGCTCCAGAGATCCA

qPCR

Sox4b qPCR R

ACGCCATGCTCCAGAGATCCA

qPCR

Sox11a qPCR F

TCTAGGTCCGTTTCCACGTC

qPCR

Sox11a qPCR R

GCTCAGGCGTGCAATAGTCT

qPCR

Sox11b qPCR F

AGTGCGCCAAACTCAAGC

qPCR

Sox11b qPCR R

CGTCGTCTTCGTCGTCAGTA

qPCR

atp5h F

TGCCATCTCAGCAAAACTTG

qPCR

atp5h R

CACAGGCTCAGGAACAGTCA

qPCR

elf1a F

CTTCTCAGGCTGACTGTGC

qPCR

elf1a R

CCGCTAGCATTACCCTCC

qPCR
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CHAPTER 5.
5.1

CHD7 AND SOX11 IN THE DEVELOPING RETINA

Summary and Discussion
To date, thousands of known genetic disorders have been identified [301].

Epidemiological studies suggest these congenital genetic disorders and structural
anomalies are present in 2-5% of live births and can be responsible for a significant
number of pediatric hospitalizations (30%) and childhood deaths (50%) [302]. Genetic
disorders are the result of a change in DNA and are grouped into three major categories:
a monogenic disorder is one that results from a pathogenic variant in one gene;
pathogenic variants in multiples genes lead to polygenic disorders; and damage to
number or structure of chromosomes leads to chromosomal disorders. To better serve
families and individuals who have been diagnosed with genetic disorders, the medical
field must continue to identify specific pathogenic variants and further understand the
role and functions of genes identified. This work not only provides answers for families
but can also provide avenues for potential new therapies.
CHARGE syndrome is a congenital disorder originally described for its major
characteristics of coloboma of the eye, heart anomalies, atresia of the choanae,
retardation of growth and development, genital anomalies, and ear anomalies
[133,135]. Additional descriptions of individuals with CHARGE have led to a much wider
and variable phenotypic spectrum and identification of causative mutations in the CHD7
gene [150]. While the major causative gene has been identified, further work is needed
to better understand its function and role in the tissues affected in CHARGE syndrome.
A significant amount of research has been completed to understand how CHD7
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contributes to the development of some tissues and systems, but there has been very
little work done on the function of CHD7 in the visual system. Furthermore,
development of the visual system requires the coordinated actions of numerous genes
along with intrinsic and extrinsic signaling pathways. This complex network controls
morphogenesis, proliferation, migration, and differentiation, leading to the
development of the specific cells and structures of the eye. Although a number of these
factors and genes have been identified, the overall picture is not complete. More work
needs to be completed to identify additional contributors and distinguish the
relationships among these genes and signaling pathways. The work described in this
dissertation provides the first steps towards addressing these gaps in our knowledge.
The goal of this dissertation was to investigate the contributions of two genes
associated with CHARGE syndrome, CHD7 and SOX11, to ocular and retinal
development. CHD7 is a member of the chromodomain helicase-DNA binding domain
(CHD) family of proteins, and as stated above is the major causative gene of CHARGE
syndrome. Previous work has shown that Chd7 expression is required in the neural
ectoderm for proper ocular morphogenesis of the optic cup and optic fissure closure,
and loss of Chd7 in a mouse knockout model results in coloboma [187]. The direct
mechanism for this defect is not understood and potential functions of Chd7 in retinal
development have not been investigated. The second gene, SOX11, is a member of the
group C family of SOX transcriptional activators. Loss of Sox11 in animal models results
in CHARGE syndrome phenotypes including coloboma, cardiac malformations and brain
defects. In addition, individuals with coloboma have been identified to have Sox11
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mutations and a chromosomal duplication involving the SOX11 locus has been identified
in an indivudal with CHARGE. However, mechanisms of how Sox11 contributes to
CHARGE syndrome phenotypes have not been identified. To that end, the experiments
described in this Dissertation address contributions of Chd7 (Chapter 2) and Sox11
(Chapters 3 and 4) to retinal and ocular development and phenotypes observed in
CHARGE syndrome.
5.2

Chd7
CHD7 has been associated with regulating tissue specific neurogenesis, including

neurons of the ear, olfactory system, and brain; mutant Chd7 animal models have
shown disruption in number and morphology of neurons in these systems
[205,207,210,252,303]. However, little is known about Chd7 contributions to the retina
and retinal neurogenesis. In Chapter 2 of this dissertation, the contribution of Chd7 in
retinal development was investigated. To begin, we characterized the expression of
Chd7 in the developing zebrafish and mouse retina. We observed broad expression in
early retina development including all the cells of the retina neuroepithelium. As
development progressed and retinal layers became distinguished the expression pattern
became more restricted to cells of the ganglion cell layer, inner cells of the inner nuclear
layer, and cells of the outer nuclear layer, at time points when these cells should be fully
differentiated. We further characterized the 3 and 5 dpf expression pattern observed in
the outer nuclear layer in zebrafish and detected co-localization with markers for cone
and rod photoreceptors. Additionally in zebrafish, we observed expression in the ciliary
marginal zone, the persistently neurogenic area of the retina. Using a meta-atlas of
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human single cell RNA-Seq data, we also discovered that in the human retina CHD7 is
expressed in neurogenic cells, retinal progenitor cells, and photoreceptor precursors in
addition to differentiated cones, retinal ganglion cells, rods, and Müller glia.
The expression pattern of Chd7 in retinal progenitor cells in zebrafish, mouse,
and human is not surprising given the known roles of Chd7 in neurogenesis. Previously
Chd7 was found to play a role in both central and peripheral neuron development. In
brain development, Chd7 expression in oligodendrocyte precursor cells demonstrated
that Chd7 was required for chromatin closing and subsequent repression of p53, the
known apoptotic inducer. Chd7 was also responsible for chromatin opening and the
activation of neuronal differentiation regulators in these oligodendrocyte precursor cells
[304]. Similarly, in cerebellar granule neuron progenitors, deficiency of Chd7 results in
increased apoptosis and decreased differentiation of these progenitors. In both
oligodendrocyte and cerebellar neuron development, Chd7 was shown to cooperate
with other chromatin remodelers (Chd8), DNA topoisomerases (Top2b), and/or
transcription factors (Oligo2/Sox10) [211,304]. In adult neurogenesis in the brain, Chd7
continues to be responsible for activation of neuronal differentiation programming in
neural stem cells in the subventricular zone of the lateral ventricle and in the
subgranular zone of the dentate gyrus in the hippocampus [303]. Furthermore, the
quiescence of these neural stem cells was demonstrated to be maintained by the
repression of positive regulators of cell cycle progression (Ccnb1, Ccnd2, Cdk1, and
Cdk2) by Chd7, however this seems to be a tissue specific regulation [305].
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In the peripheral nervous system, loss of Chd7 in the developing inner ear results
in smaller vestibulo-cochlear ganglia size and less inner ear neuroblasts as result of
decreased proliferating progenitors. While there were no changes in the quantification
of apoptosis similar to what was observed in brain development there was a significant
decrease in expression of inner ear neurogenic genes (Fgf10, Ngn1, NeuroD and Isl1)
suggesting that Chd7 also regulates differentiation [205]. In addition, the loss of Chd7 in
developing olfactory neural stem cells results in a significant reduction in olfactory
sensory neurons as a result of decreased proliferation and differentiation. Furthermore,
there is a delayed and impaired ability for the adult olfactory epithelium to respond to
damage after ablation suggesting Chd7 is also required for neuronal regeneration of the
olfactory epithelium [206].
The broad expression of Chd7 in the retinal neuroepithelium and the ciliary
marginal zone are evidence that Chd7 contributes to progenitor pool maintenance.
Given what is observed in the progenitors of the inner ear and olfactory bulb, Chd7
could contribute to retinal neural progenitors by promoting proliferation and ensuring
the correct number of progenitor cells. Additionally, Chd7 could be repressing apoptosis
as observed in brain development allowing for the progenitor population pool to also
remain the correct size. Either or both activation of proliferation or repressing apoptosis
could explain the microphthalmia that we observe in chd7 mutants, since a decrease in
number of progenitors will eventually result in a decrease in final retinal cell number. In
addition, Chd7 could be playing a role in specification of retinal progenitors towards
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various lineages, particularly of the cone photoreceptors given the significant decrease
in cones we observed in chd7 mutants.
To test the role of Chd7 in progenitor pool maintenance and retinal cell
specification several experiments should be completed. First, regarding progenitor pool
maintenance, experiments to detect proliferation and cell death could be completed at
early timepoints in the zebrafish retina (24 – 48 hpf). Using tools like EdU (5-ethynyl-2’deoxyuridine) and TUNEL (Terminal deoxynucleotidyl transferase dUTP nick end)
labeling we would expect to observe a decrease in EdU labeling and/or increase in
TUNEL labeling in the chd7 mutants compared to wild type. In addition, further analysis
of the ciliary marginal zone in chd7 mutants compared to wild type could be completed
with PCNA (proliferating cell nuclear antigen) staining. To examine Chd7’s role in cone
lineage specification, it would be useful to perform quantitative and spatial expression
analysis of known photoreceptor lineage specification genes, such as Crx, which is
expressed in all photoreceptor precursors, NeuroD , Nrl, and Nr2e3 (expressed in rod
precursors), and Gdf6a and Six7 (expressed in cone precursors) at 48 – 72 hpf, the
window during which zebrafish photoreceptors are terminally differentiating. If Chd7 is
required for cone photoreceptor lineage specification, I would expect to observe less
expression for cone genes but no change for in expression of rod specification genes.
Furthermore, zebrafish provide another opportunity due to their transparent
development allowing for live imaging studies. Time lapse imaging from 48 – 96 hpf of
progeny from the chd7 mutant line crossed with the TαC:eGFP line (which fluorescently
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labels all cone photoreceptors) could reveal defects in cone photoreceptor
differentiation upon loss of Chd7.
While Chd7 has well-known roles in neural stem and progenitor cells, we were
somewhat surprised to observe its expression in terminally differentiated retinal cells.
This retinal expression has not been described before now and previous descriptions of
Chd7 expression in mature neurons have been limited to spiral ganglion and vestibular
neurons of the ear, cerebellar granule neurons, and some interneurons in the olfactory
bulb. However, little is known about the function of Chd7 in these mature neurons
[211,306,307]. Differentiated retinal cell expression could suggest a role for Chd7 in
maturation, maintenance, or a specific physiological function in retinal neurons. After
retinal cell types have terminally differentiated, they must mature to be fully functional.
Maturation includes axon growth, dendrite stratification, and formation of synaptic
connections between pre- and post-synaptic partners. Chd7 has been implicated in
establishing dendritic morphology in brain development in mouse mutant models and
in-vitro human neural cell induction models [303,308]. The Drosophila homolog of Chd7,
Kismet, has been found to play a role in axon pruning and migration in addition to
playing a role in neurotransmission at pre-synaptic neurons [180,309,310]. A target of
CHD7, Sema5b, has been shown to have a role in synaptogenesis and axon growth and
both Chd7 and Sema5b have been implicated in autism spectrum disorders, further
suggesting a role in synapse development[311,312]. Taken together, these previous
results suggest that in the retina Chd7 could be contributing to many aspects of retinal
neuron maturation. The maturation of retinal neurons in our chd7 mutants should be
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explored with immunohistochemistry experiments labeling axonal and synaptic
proteins, such as Synaptophysin, Bassoon, and PSD-95. Transmission electron
microscopy could also be used to further explore any potential deficits in synaptic
terminal formation.
To further investigate the contribution of Chd7 in the photoreceptors, we
characterized retinal phenotypes in mouse and zebrafish Chd7 mutant models. In both
zebrafish and mouse Chd7 mutants, we found a significant decrease in the number of
cone photoreceptors. Additionally, both rod and cone mutant photoreceptors had
truncated outer segments. We did not observe other obvious retinal cell defects;
however, more careful observations need to be completed to detect any potential
subtle defects. Why are cones reduced in chd7 mutants? As described above, it may be
that Chd7 is required for the proper specification of the cone lineage. Alternatively,
Chd7 may have critical function in maturation or maintenance of newly differentiated
cones, and its absence could lead to cone degeneration. We did not observe an increase
in apoptosis in the retina at 5 dpf, suggesting that mature cones are not degenerating.
However, cone cell death should be explored by TUNEL staining at earlier stages prior to
the 5 dpf timepoint we have already completed. These results should delineate whether
cones are not being specified or are being specified and dying.
The truncated outer segments we observed in both zebrafish and mouse Chd7
mutant photoreceptors strongly implicates a role for Chd7 in photoreceptor outer
segment morphogenesis or maintenance. The identification of this novel role in mouse
and zebrafish leads to questions about visual function is these mutants. In addition, is
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this role conserved in humans? If so, do individuals with CHARGE have underlying
photoreceptor defects that have not been identified? And could this potentially explain
why there is no direct correlation between severity of ocular malformations and visual
acuity in individuals with CHARGE? [178].
To further examine the cause of this truncated outer segment phenotype,
transmission electron microscopy could be completed on wild type and mutant larvae to
identify the precise nature of the outer segment defects and determine whether the
structural problems are occurring in specific locations such as the axoneme or outer
segment disc/folds. Additionally, live imaging with chd7 mutant TαC:eGFP and XOPS:GFP
larvae could determine if outer segments never develop properly, or whether they
develop and then degenerate.
In addition, it will be important to determine the consequences due to loss of
cones and truncated outer segments in Chd7 mutants: does this lead to deficits in visual
function? Visual behavior in mutant zebrafish could be assessed through an optokinetic
response test, where zebrafish larvae are presented with a moving pattern of
alternating black and white vertical stripes and eye movements are observed. An
electroretinogram should also be completed to more precisely assess visual function
upon loss of Chd7.
Identification of the genes regulated by Chd7 in retinal development should also
be investigated using a combination of sequencing techniques. Transcriptomic analysis
of wild type versus chd7 mutant retinas at 24 and 48 hpf could elucidate roles of Chd7 in
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maintenance and specification of the retinal progenitor pool. Specific genes related to
proliferation and photoreceptor precursors should be analyzed. Transcriptomic analysis
using fluorescence-activated cell sorting (FACS) of rod and cone photoreceptors of wild
type versus chd7 mutant retinas could identify potential genes involved in the truncated
outer segment phenotype. Genes involving photoceptor outer segment development
and maintenance could be identified in this process. These genes could include those
related to the development of the cilia structure (axoneme/microtubules) or perhaps
elongation and formation of disc/folds. Alongside these transcriptomic analyses, it
would be beneficial to also complete CUT&RUN sequencing in the same tissue and
timepoints to distinguish the direct vs. indirect targets of Chd7. In addition, completing
ATAC-sequencing in mutant and wild type retinas would determine if Chd7 is controlling
chromatin accessibility at these targets and other areas of genome. Data gathered from
these sequencing experiments are essential in identify the specific targets and roles of
Chd7 in retinal development.
We have demonstrated that loss of Chd7 results in retinal phenotypes in mouse
and zebrafish, but it is important to investigate whether these phenotypes may also be
present in humans. While to our knowledge retinal cell defects have not been
documented in individuals with CHARGE, it could be possible that they are being
masked by the overlying ocular malformations and more careful ophthalmic
examinations need to be completed. However, this task could be challenging due to the
syndromic nature of CHARGE syndrome, making it difficult to perform lengthy and
complex ophthalmic assessments in young individuals. Another option is to use human
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retinal organoids, which are three-dimensional structures derived from stem cells and
have been shown to be effective in-vitro models for retinal development and diseases
[313]. These organoids could be used to observe the expression and function of CHD7 at
different stages of human retinal cell type development. Furthermore, using either
human induced pluripotent stem cells from an individual with CHARGE or CRISPR-Cas9
mediated genome editing, retinal organoids could be developed in a setting deficient of
CHD7 to investigate potential retinal phenotypes and their underlying pathogenetic
mechanisms.
Finally, it is interesting that although we observed gross morphological defects in
the zebrafish chd7 mutants such as craniofacial abnormalities, lack of a swim bladder,
heart defects, and microphthalmia, we did not observe the common CHARGE
phenotype of coloboma. The rapid window of ocular morphogenesis in zebrafish;
compensation by another Chd family member such as Chd5 which has been shown to
contribute to zebrafish eye development [254]; or differences in molecular mechanism
of choroid fissure closure in zebrafish could all potentially explain this lack of coloboma.
Expression analysis of other Chd family members during critical timepoints of choroid
fissure formation and closure could be completed in wild type and mutant embryos to
identify any potential sources of compensation. Although not trivial, the generation of a
fluorescently tagged Chd7 transgenic line could also allow for live imaging for
observation of any contribution of Chd7 to choroid fissure closure in zebrafish and
specifically the required basement membrane rearrangement. Moreover, given the
known function of Chd7 in neural crest cell development, and the contribution of neural
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crest cells to ocular development and optic fissure closure, it would be interesting to
investigate whether neural crest cell specification, migration, and differentiation,
particularly in the periocular mesenchymal cells, are altered in the chd7 mutants
[232,256,314,315]. Preliminary studies could be completed using live imaging of
zebrafish transgenic lines that have fluorescently labeled neural crest cells. Perhaps
there are subtle or no defects in the neural crest cell dynamics and thus coloboma does
not result.
5.3

Sox11
As described in Chapter 2, we have shown that the loss of Chd7 results in a

spectrum of deficits. Given that Chd7 is a chromatin remodeler it is essential to identify
its potential downstream target genes. In Chapters 3, 4, and the Appendix, I describe the
work I performed to generate and characterize knockout and knock-in zebrafish lines for
one known Chd7 target gene: Sox11. I designed and carried out CRISPR-Cas9 genome
editing experiments to generate zebrafish sox11 mutants as well as an epitope-tagged
Sox11 knock-in line. With these lines we will be able to further describe and identify
specific genes involved in retinal and ocular development.
First, for the knockout lines, we designed our CRISPR targets sites to cause
disruption to the two functional domains of the co-orthologues of Sox11, sox11a and
sox11b. While we initially struggled to establish germline transmission from our
founders, we were eventually successful in establishing stable mutant lines for both
sox11a and sox11b which have large intragenic deletions resulting in severely truncated
proteins. We also found it necessary to establish maternal zygotic mutant lines given
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the maternal deposition of sox11a and sox11b mRNA into the oocyte [275]. These lines
demonstrated non-sense mediated decay when evaluated for mRNA expression,
suggesting they both carry null alleles. However, I also observed evidence of genetic
compensation in each mutant by either a co-orthologue (in the case of the sox11a
mutant) or from upregulated expression of another SoxC family member (in the case of
the sox11b mutant). This compensation is not unexpected, given our data on
redundancy of SoxC co-orthologs from previous morpholino studies as well as known
redundancy between SoxC members in other animal models [233,234,316]. This means
that generation and characterization of double and quadruple mutants should be
completed to eliminate the observed compensation.
Despite this compensation, we observed some retinal phenotypes in our single
maternal zygotic mutants. In both sox11a and sox11b MZ mutants, there was a small
but significant decrease in rod photoreceptors, similar to what was observed in both
sox11a/b and sox4a/b morphants [233,234]. In the morphants, this phenotype was a
result of a defect in terminal differentiation of rod photoreceptors and not an early
defect in photoreceptor precursor specification. This mechanism also seems to be
supported in the CRISPR mutants given that we see no loss of cone photoceptors;
however, in-situ hybridization experiments with probes for those early photoreceptor
lineage genes (crx, neuroD, nrl, nr2e3) should be completed in these mutants.
We observed a smaller lens in sox11b mutants, a phenotype also previously
described in sox11 morphants and Sox11-deficient mouse and frog models [234,294]. In
previous studies, loss of Sox11 was associated with increased levels of Hedgehog
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signaling. Sox11 was proposed to maintain correct levels of Sonic Hedgehog a (shha) by
activating the upstream repressor, bmp7b. Therefore, shha and bmp7b expression
levels should be investigated in the sox11 mutant lines to determine whether this
pathway is also disrupted in the CRISPR mutants.
It is interesting to note that microphthalmia and/or coloboma have been
described in other Sox11 deficient organisms including zebrafish morphants, mouse
knockouts, frog morphants, and individuals with CHARGE, but coloboma was not
detected in either of our CRISPR mutants [234,285,288,294]. This lack of phenotype
could be a result of the genetic compensation and redundancy described above, and
thus it might take generation of double (sox11a-/-sox11b-/-) or quadruple (sox4a-/-sox4b-/sox11a-/-sox11b-/-) mutants to induce coloboma phenotype in this system; we are
currently performing the crosses to generate these double, triple, and quadruple
mutants. In addition, other retinal cell defects should be further investigated given the
reduction of retinal ganglion cells and other retinal neurons observed in double
Sox4/Sox11 mouse mutants [292,317,318].
Our currently described phenotypes of the loss of rod photoreceptors and lens
malformation are consistent with previously described Sox11 models and suggest at
least two roles of Sox11 in ocular development. One role for Sox11 is in early ocular
morphogenesis while the other role is in retinal neurogenesis. While morphant and
mutant phenotypes are similar, the generation of permanent knockout models in
zebrafish allows for us to examine loss of Sox11 beyond embryonic and larval stage. This
provides us the opportunity to examine the role in Sox11 in both early and continued
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retinal neurogenesis in addition to its role retinal regeneration. Furthermore,
identification of other deficits may result from the continued absence of Sox11 thus
making it another model for the human disorders involving Sox11.
To further characterize the role of Sox11 in ocular morphogenesis and retinal
neurogenesis, it is important to identify the direct downstream targets of Sox11 during
these specific developmental processes. However, as stated in Chapter 3 this can be a
challenge in zebrafish given the lack of reliable antibodies. This is where the epitope
tagged knock-in lines for both co-orthologues of Sox11 will be useful. Using available
design tools and CRISPR-Cas9 genome editing, we designed and established a MYCSox11a knock-in line. We validated MYC-Sox11a mRNA and protein expression in this
line; however, protein expression was not detectable by conventional
immunohistochemistry, necessitating a signal amplification step to observe the retinal
expression pattern. This suggests that low expression of the endogenous SoxC genes
present a challenge for immunodetection, even with a reliable antibody to the epitope
tag [298]. This led us to design a 2xHA donor for our sox11b knock-in in hopes of
boosting signal detection; we are currently working to identify potential founders from
these injections. Importantly, with the establishment of these lines, we can not only
perform more precise immunohistochemistry experiments to further investigate Sox11
expression patterns in the retina, but we can also perform experiments like CUT&RUN
to identify direct Sox11 target genes. Identifying these genes will be essential in
understanding the molecular mechanisms that Sox11 controls in development.
Furthermore, given the overlapping expression pattern of chd7 with sox11a and sox11b
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in the early retina, it will be interesting to note if there are common molecular targets
found between CUT&RUN datasets with chd7, sox11a, and sox11b or potentially any
direct regulation between the three genes.
In addition to the ocular and retinal phenotypes, we observed craniofacial
defects, heart edema, and curved bodies in our sox11 mutants. These defects resemble
those we observed in in our chd7 mutant and are found in tissues that are derived from
neural crest cells. Given that CHD7 and SoxC transcription factors are both expressed in
neural crest cells it is important to investigate the potential relationship between Sox11
and Chd7 in neural crest cell dynamics [194,196,239,319,320]. Since Chd7 has been
shown to regulate expression of Sox11 in neural stem cells, I hypothesize that there is
similar regulation in neural crest cells [208]. This can be investigated by quantifying
Sox11 expression in cells using fluorescence-activated cell sorting (FACs) to sort
fluorescently labeled neural crest cells from sox10:RFP and foxD3:GFP transgenic lines in
wild type and chd7 mutants. We would expect a decrease in expression of Sox11 in the
chd7 mutant cells. In addition, CUT&RUN sequencing could also be completed from
FACs sorted neural crest cells to identify a potential direct relationship.
5.4

Conclusion
The work in this dissertation examines the contributions of Chd7 and Sox11 to

ocular and retinal development and their potential connections to CHARGE syndrome.
Through detailed efforts this dissertation describes a novel expression and role for Chd7
in retinal neurogenesis and the generation and characterization of Sox11 knockout and
knock-in lines. The results described in this dissertation point to roles for Chd7 and
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Sox11 in the maintenance of early retinal progenitors and for Chd7 in differentiated
retinal cells as well as Chd7 and Sox11 in the development of tissues derived from
neural crest cells. Furthermore, co-expression analysis in the developing retina suggests
that Chd7 may regulate expression of Sox11, similar to its previously described activity
in adult neural stem cells (Figure 5.1). My results raise several important questions: (1)
what are the downstream targets of Chd7 in the retina, and (2) does CHD7 play the
same role in humans as in zebrafish and mouse? Future work could address these
questions with more detailed studies in individuals with CHARGE as well as further
characterization of our mutant and knock-in zebrafish models. In summary, this work
provides new genetic tools and future avenues for investigation into the molecular
underpinnings of ocular and retinal development, and a better understanding of the
pathogenesis of genetic disorders involving the eye such as CHARGE syndrome.
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Figure 5.1 Pathways for Sox11 and Chd7 in Ocular and Retinal Development

Figure 5.1 Pathways for Sox11 and Chd7 in Ocular and Retinal Development. Proposed
interaction between Sox11 and Chd7; direct regulation by Chd7 (black dashed arrows)
or co-regulation with Chd7 (purple dashed arrows).
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APPENDIX
APPENDIX 1. PROGRESS TOWARDS GENERATING A KNOCK-IN HA-TAGGED SOX11B
ZEBRAFISH LINE
A1.1 Introduction
Disruptions in human SOX11 have been associated with congenital disorders
including CHARGE syndrome, Coffin-Siris syndrome, and other developmental
abnormalities involving neural and ocular tissue [235,321–323]. Sox11 is a member of
the SoxC transcription factor family and in animal models has been associated with roles
in organogenesis, neurogenesis, craniofacial, and skeletal development [324–326]. As
shown in Chapter 4 and previous reports from our lab, disruptions in the two zebrafish
co-orthologs of Sox11, sox11a and sox11b, result in phenotypes similar to those of
human individuals [234]. However, very few direct targets of these transcription factors
have been identified, thus preventing a deeper understanding of the mechanistic details
of the observed phenotypes. Development of endogenously tagged sox11a/b zebrafish
lines allows for further investigation into the function and the direct targets of these
transcription factors. Chapter 3 describes the process and validation of the development
of a MYC-Sox11a knock-in line. While we had successful insertion of 1xMYC tag in-frame
of sox11a, the low endogenous expression levels of MYC-sox11a made
immunohistochemical detection challenging, requiring additional signal amplification
procedures. To improve on this we designed a 2x”tag” when working to establish a
sox11b knock-in line. In this appendix, I describe progress toward developing a 2xHASox11b knock-in line.
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A1.2 Materials and Methods
A1.2.1 Zebrafish Maintenance
Zebrafish were bred, raised, and housed at 28.5°C on a 14-hour light:10-hour
dark cycle in compliance with established protocols for zebrafish husbandry [241]. All
animal procedures were carried out in accordance with guidelines established by the
University of Kentucky Institutional Animal Care and Use Committee and the ARVO
Statement for the Use of Animals in Ophthalmic and Vision Research. Wildtype zebrafish
(AB strain) were obtained from the Zebrafish International Resource Center (ZIRC,
Eugene, OR).
A1.2.2 CRISPR Design and Microinjections
The sox11b target site and donor template were designed using the Integrated
DNA Technologies Alt-R™ CRISPR HDR Design Tool
(https://www.idtdna.com/pages/tools/alt-r-crispr-hdr-design-tool; IDT, Coralville, IA).
The target site for genome editing was selected in the 5’UTR of sox11b, 20 base pairs
(bp) upstream of the start codon. The donor template sequence was designed with the
HA tag sequences and linker sequences placed just after the start codon and included 40
bp of left arm and 80 bp of right arm homology (Figure A1.1). The donor templates
were synthesized and supplied by IDT as modified Alt-R HDR Donor Blocks.
The Alt-R CRISPR-Cas9 crRNA was synthesized by IDT and was duplexed with AltR CRISPR-Cas9 tracrRNA (IDT: 1073190) in a Eppendorf Mastercycler with the following
program: 95°C for 5 minutes, cooling to 25°C at a rate of 0.1°C/second, (Eppendorf,
Enfield, CT). Cas9 protein was purchased as Alt-R® S.p. Cas9 Nuclease V3 (IDT:
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1081058). One-cell stage embryos were injected with 250 pg gRNA, 500 pg Cas9, 37.5
pg HDR template, and Dextran red.
A1.2.3 Insertion Screening
Genomic DNA (gDNA) was extracted from whole embryos or tails of injected
adult fish or their progeny. Tissue was placed in 50mM sodium hydroxide and incubated
at 95°C for digestion. The solution was neutralized with 1 M Tris-HCl, pH 8.0. The gDNA
was PCR amplified using primers described in Table A1.1. Products were visualized on a
3% agarose gel. Products that matched the expected insertion size were extracted from
the gel into dialysis tubing (Thermo Scientific: 88243, Rockford, IL), ligated into pGEM-T
Easy (Promega: A1360, Madison, WI), and sequenced with universal T7 and Sp6 primers
(Eurofins Genomics Services, Louisville, KY).

152

Figure A1.1 Knock-in design for 2xHA-sox11b

Figure A1.1 Knock-in design for 2xHA-sox11b. A. Schematic of sox11b locus, including
Cas9 target site (scissors) and HA-donor template. SL, short linker sequence; GSG, GSG
Linker sequence.

Table A1.1 Target and Primer Sequences
Primer

Sequence

Use

sox11b F

actagttaagaaggcagtcgg

Screening

sox11b R

tcatgggtcgtttgatgtgg

Screening

crRNA

agctgctagagtctatcaag

A1.3 Results
A.1.3.1 Knock-in design and donor template production
Similar to our methods in Chapter 3 for the Sox11a-MYC line we utilized the
synthetic crRNA-tracrRNA and Cas9 ribronucleoprotein (RNP) complex developed by
Integrated DNA Technologies (IDT) in addition to IDT’s HDR Design Tool to choose the
target site and donor sequence. We chose a crRNA that provides a target site 20 base
pairs (bp) upstream of the sox11b transcription start site (Table A1.1). For the donor
design, we included 40 bp left homology and 80 bp right homology arms as this
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previously worked well for sox11a. However, instead of a single epitope tag like we
described in Chapter 3, for this line we designed a donor sequence that contains a
double HA epitope sequence that is separated with a short linker sequence and is
separated from the downstream sox11b sequence by a GSG linker sequence. This design
results in a 215 bp donor template (Figure A1.1) which we hope will permit easier
detection of the epitope tag compared to the single MYC epitope described in Chapter
3.
A.1.3.2 Screening for the knock-in
Wildtype zebrafish embryos were microinjected with the sox11b targeting
crRNA-tracrRNA duplex and Cas9 protein complex along with the donor template at the
one cell stage. Injected embryos were raised to adulthood and tail clipped for genomic
DNA extraction. We analyzed the DNA by polymerase chain reaction (PCR) with primers
located on either side of the expected insertion site. Based on the length of the 2xHA
epitope tag and linkers, successful HDR would result in a 69 bp insertion, producing an
amplicon of 315 bp compared to the wildtype size of 246 bp (Figure A1.2). 153 total fish
were analyzed for insertion and 7 were observed to have a larger band of the expected
size (Table A1.2). These bands are currently being further analyzed by sequencing to
confirm insertion of donor sequence.
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Figure A1.2 2 CRISPR Knock-in injection tail clip screen

Figure A1.2 CRISPR Knock-in injection tail clip screen. Example of 3% agarose gel used
to screen PCR products from injected embryos for evidence of insertion. Asterisks
represent sample that displays an upper band of the correct size for 2xHA insertion; 1-4,
fish screened; UN, uninjected.

Table A1.2 Knock-in founder screening

sox11b 2xHA

Total Screened

Appeared
as WT

Evidence of
Insertion

153

146

7

A1.4 Conclusion
SOX11 is a transcription factor associated with several different congenital
disorders in addition to retinal and ocular deficits. To better understand the
pathogenesis of these deficits, as well as the normal function of Sox11 during retinal
development, identification of the direct molecular targets of Sox11 in the retina is
essential. This could be done using assays such as ChIP-Seq or CUT&RUN but is
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challenging to perform in zebrafish due to the lack of commercially available antibodies
for zebrafish Sox11. Therefore, epitope-tagged transgenic lines would be valuable tools
for further studies.
Previously we have successfully generated a MYC-Sox11a knock-in line with
similar design for the CRISPR target site and homology arms [298]. In that line, we
designed a 1xMYC insertion for the epitope tag. While we were successful at getting an
in-frame insertion of MYC, the low endogenous expression levels of this gene made it
challenging to detect by immunohistochemistry. Therefore, with this design we included
a 2xHA epitope tag in hopes of promoting easier detection by IHC. Given the observed
larger bands on gel analysis we predict that there has been some incorporation of our
donor template. However, further analysis is needed to confirm this insertion and
ensure that the tag is in-frame and functional and without other off-target insertions.
Successful establishment of two separate tagged lines for sox11a and sox11b will
allow for downstream experiments to further characterize function and allow for
experiments like CUT&RUN and deep sequencing to identify potential targets. These
lines could be instrumental in understanding the role of Sox11 during retinal
development and the pathogenetic mechanisms underlying Sox11 related disorders.
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